Refining pre-polysomnography suspicion of Obstructive Sleep Apnea Syndrome: Logistic and Bayesian analysis of clinical factors by Liliana Patrícia Pinto Leite
Refining pre-polysomnography suspicion of 
Obstructive Sleep Apnea Syndrome: Logistic 
and Bayesian analysis of clinical factors 
Liliana Patrícia Pinto Leite 
October|2012  
 
5
th
 ed. 
 
i 
 
 
Refining pre-polysomnography suspicion of 
Obstructive Sleep Apnea Syndrome: Logistic and 
Bayesian analysis of clinical factors. 
Liliana Patrícia Pinto Leite 
October|2012  
 
Pedro Pereira Rodrigues, Faculdade de Medicina da Universidade do Porto 
 
Cristina Santos, Faculdade de Medicina da Universidade do Porto 
 
5
th
 ed 
  
iii 
 
Acknowledgements 
This thesis is the culmination of one more academic step which means so much more than that. This 
Masters has given me the unique experience of meeting unbelievable people and acquiring knowledge that 
has allowed me to grow as a human being. 
 
I want to thank all the people who were with me, in some way, during this process, either directly or 
indirectly. 
 
To my parents, for all the lessons, love and sacrifices made throughout my life that really helped me to 
always overcome the difficulties. 
 
To my mentors for instantly accepting this project with all the enthusiasm and dedication. 
 
To Prof. Pedro Pereira Rodrigues for all the patience and teaching, for setting me objectives and 
challenges for which I thought I could not reach. 
 
To Prof. Cristina Santos for the enthusiasm, interest and availability in the area. 
 
To the Sleep Laboratory team of Vila Nova de Gaia Hospital Center for helping me on the work 
development, especially to my colleagues and friends of all hours, Dr. Gisela Fontes and Dr. Fernanda 
Azevedo for ensuring me the necessary schedule shifts that allowed me to attend the course and for 
helping me in the data collection. 
 
To Pedro who encouraged me to attend the Masters, for all the love and patience and for making me 
always believe that it is worth fighting for and learning. 
 Resumo 
Introdução: A Síndrome da Apneia Obstrutiva do Sono (SAOS) é uma doença que afecta 2-4% da 
população em todo o mundo. O método padrão para o diagnóstico de SAOS é a polissonografia (PSG), 
um exame caro, limitado às áreas urbanas e, consequentemente, com grandes listas de espera. 
 
Objectivo: Definir um método auxiliar de diagnóstico que prioriza os pacientes, durante a consulta do sono, 
para a realização da PSG, de acordo com a probabilidade de diagnóstico de SAOS. 
 
Métodos: Um estudo prospectivo foi realizado, incluindo pacientes adultos com suspeita de SAOS que 
realizaram PSG no laboratório do sono do Centro Hospitalar de Vila Nova de Gaia / Espinho. As 
variáveis estudadas foram definidas a partir de revisão de literatura e recolhidas durante a consulta. Foram 
colhidas duas amostras: uma coorte de treino para desenvolver os modelos e verificar a sua validade 
interna e externa através da validação cruzada (VC), e uma coorte de validação para verificar a aplicação 
dos modelos resultantes na prática clínica. Com as variáveis significativas obtidas na regressão logística 
(RL) univariada foram utilizadas duas técnicas diferentes para construir os modelos: RL múltipla e redes 
Bayesianas usando os classificadores Naïve Bayes (NB) e Tree Augmented Bayesian Network (TAN). A 
sensibilidade e especificidade foram analisadas para determinar a respectiva performance. 
 
Resultados: Foram estudados 86 pacientes para construir os modelos, 52% dos quais com diagnóstico de 
SAOS. A RL univariada mostrou seis variáveis com influência significativa no resultado: sexo masculino 
(OR = 7,259, IC 95% = [1,096; 27,651]), índice de massa corporal (OR = 1,159, [1,030; 1,303]) 
circunferência do pescoço, (OR = 1,341, [1,159; 1,550]), circunferência abdominal (OR = 1,076, [1,025; 
1,129]), apneias presenciadas (OR = 4,725, [1,772; 12,599]) e álcool antes de dormir (OR = 3,307, [1,350; 
8,100]). Foram testados dois diferentes limites de sensibilidade. Com o intuito de obter 100% de 
sensibilidade foi utilizado um limite de 10% na RL obtido após a análise da curva ROC (AUC = 80% 
[70%, 89%]), 7% no NB e 2% no TAN, enquanto que se pretendermos 95% de sensibilidade, os limites 
obtidos foram de 25% na RL, 10% para o NB e 22% no TAN. A VC da RL estima que e é robusto para 
ambos os limites: 98% para a sensibilidade e 11% para a especificidade e 89% -34%, respectivamente. No 
NB, usando 7% como limite, os resultados foram de 98% para a sensibilidade e de 18% para a 
especificidade, com o limite mais elevado (10%), os resultados foram de 93% de sensibilidade e de 30% de 
especificidade. No TAN, usando 2% como limite, os resultados foram de 88% de sensibilidade e 23% de 
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especificidade e com o limite de 22% foram de 84% sensibilidade e 25% de especificidade. Estes modelos 
foram testados numa segunda amostra comparável de 33 pacientes para avaliar o seu desempenho na 
prática clínica. Os resultados da RL apoiam as expectativas de ambos os limites (10% e 25%): 100% -0% e 
88% -15%, respectivamente. Os limites de 7% e 2% usados para o NB e TAN respectivamente, obtiveram 
a mesma sensibilidade (94%), mas o TAN obteve melhor resultado relativamente à especificidade (7%) do 
que o NB (0%). Utilizando os limites mais elevados, 10% para o NB e de 22% para o TAN, os dois 
classificadores obtiveram mais uma vez a mesma sensibilidade (89%), mas o TAN revelou melhor 
resultado de especificidade (13%) do que o NB (7%). 
 
Discussão: A circunferência do pescoço e apneias presenciadas fornecem informação suficiente para um 
modelo clínico com base nos resultados da RL. Se optarmos por redes Bayesianas devemos usar mais 
variáveis: sexo, índice de massa corporal, circunferência abdominal e álcool antes de dormir. Para ambos 
os modelos, utilizando os limites respectivos, podemos elaborar três níveis de prioridade dada a 
probabilidade de o paciente ter diagnóstico de SAOS: o grupo não prioritário, um nível intermédio e, por 
fim, um grupo de alta prioridade. Além destes resultados, o uso das redes revela duas principais vantagens 
que a RL tradicional não pode resolver. Primeiro, as redes Bayesianas podem lidar com informações em 
falta, e em segundo lugar, permitem uma representação gráfica que pode ser mais interessante para o 
médico. Consideramos que o uso destes modelos na consulta do sono pode ser uma ferramenta útil para a 
triagem de pacientes que realizem PSG e pode, eventualmente, ajudar a priorizar os doentes, permitindo 
talvez reduzir o número de PSG com resultado normal. 
 
Palavras-chave: factores de risco, Síndroma da Apneia Obstrutiva do Sono, diagnóstico, modelo clínico, redes Bayesianas, 
sensibilidade e especificidade. 
 Abstract 
Introduction: Obstructive Sleep Apnea (OSA) is a disease that affects 2-4% of the population around the 
world. The standard method for OSA diagnosis is polysomnography (PSG), an expensive exam, limited to 
urban areas and, consequently, with long waiting lists. 
 
Aim: To define an auxiliary diagnostic method, that prioritizes patients during pre-polysomnography 
consultation, according to their probability of OSA diagnosis. 
 
Methods: A prospective study was conducted, including adult patients with OSA suspicion that performed 
PSG at the Sleep Laboratory of Vila Nova de Gaia/Espinho Hospital Center. The studied variables were 
defined from literature review and collected during consultation. Two samples were collected: a training 
group to build the models and check internal and cross-validation (CV) and a validation group to check 
the resultant models in clinical practice. With the significant variables achieved with univariate logistic 
regression (LR) we used two different techniques, multiple LR and Bayesian networks classifiers- Naïve 
Bayes (NB) and Tree Augmented Bayesian network (TAN) - to build models that predicts OSA diagnosis. 
The sensitivity and specificity was analyzed to determine their performance. 
 
Results: We studied 86 patients in order to build the models, 52% with OSA diagnosis. Univariate LR 
analysis showed six variables with significant influence on the outcome: male gender (OR=7.259, 95% 
CI=[1.096;27.651]), body mass index (OR=1.159, [1.030;1.303]), neck circumference (OR=1.341, 
[1.159;1.550]), abdominal circumference (OR=1.076, [1.025;1.129]), witnessed apneas (OR=4.725, 
[1.772;12.599]) and alcohol before sleep (OR=3.307, [1.350;8.100]). We tested two different cutoffs for 
sensitivity. Aiming 100% of sensitivity we used a 10% cutoff on LR achieved after a ROC curve analysis 
(AUC=80% [70%;89%]), 7% on NB and 2% on TAN while aiming 95% for sensitivity the cutoffs were 
25% on LR, 10% for NB and 22% on TAN. The CV validation of LR model estimates that it was robust 
for both cutoffs (10% and 25%): 98%-11% and 89%-34%, respectively. On NB, using 7% as cutoff, the 
results were 98% for sensitivity and 18% for specificity and with the higher cutoff (10%) the results were 
93% to sensitivity and 30% for specificity. On TAN, using 2% as cutoff, the results were 88% to 
sensitivity and 23% for specificity and to 22% were 84% to sensitivity and 25% for specificity. These 
models were tested on a separate comparable 33-patients cohort to analyze their performance on clinical 
practice. Results of LR supported the expectations for both thresholds: 100%-0% and 88%-15%, 
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respectively. The 7% (NB) and 2% (TAN) cutoffs obtained the same sensitivity (94%), but TAN achieved 
better results on specificity (7%) than NB (0%). Using the higher cutoffs of 10% on NB and 22% for 
TAN, the two classifiers obtained once again the same sensitivity (89%) but better results for specificity 
on TAN (13%) than in NB (7%). 
 
Discussion: Neck circumference and witnessed apneas information suffices to a clinical model based on the 
LR results. If we use a BN we need more two variables: gender, body mass index, abdominal 
circumference and alcohol before sleep. For both models using the respective cutoffs we can provide 
three levels of priority given the probability of the patient having OSA diagnosis, non-priority group, an 
intermediate level and, finally, a priority group. Besides these results, the use of BN reveals two main 
advantages that traditional LR cannot solve. Firstly, BN can deal with missing information; second, the 
graphical representation can be more interesting to the physician. We consider that the use of these 
models on sleep consultation can be a helpful tool to monitor patients to perform PSG and eventually 
reduce the number of normal results PSG. 
 
Key-words: risk factors, obstructive sleep apnea, diagnosis, clinical model, Bayesian network, sensitivity and specificity. 
 
 
 
 
 
 
 
 
 Preamble 
 
The mysteries of sleep have always fascinated me which very naturally led me to a neurophysiology course. 
Luckily, my professional career began 8 years ago on the sleep laboratory of Vila Nova de Gaia/Espinho 
Hospital Center and the interest in the area has not decreased ever since. 
 
The science of sleep is still very recent and we are still discovering new findings every year, new 
associations between sleep disorders and other diseases and, therefore, the increased interest in the area. 
Who has never had a sleepless night and all the unpleasant symptoms the next day? Sleep is a physiological 
need, so important as eating or drinking and we must give due attention in order to guarantee our well-
being. 
 
The evidence of the importance of sleep is reflected on long waiting list that we have in our laboratory, 
either for consultation or to perform polysomnography, which led me to wonder if we could find a way to 
manage all these cases, diagnosing and treating first the most severe cases, optimizing the available 
resources. 
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Thesis organization 
In chapter 1 (Introduction) we make an introduction to the problem that motivates this thesis and 
explains the solutions tested and the various methods developed to screen patients to perform 
polysomnography (PSG). 
 
In Chapter 2 (Aim) we set the main objective which is to define an auxiliary diagnostic method that can 
support the decision to perform polysomnography, or prioritize the waiting list to polysomnography. 
 
In Chapter 3 (Background) various definitions are quoted to help in the thesis perception. Concepts like 
sleep apnea, risk factors to OSA, logistic regression and Bayesian networks are explain. 
 
In Chapter 4 (Methods) we present the methodology used to develop and evaluate the models, including 
variables collected, the selection criteria used to select the two samples, the parameters used to construct 
two models based in logistic regression and Bayesian networks and finally the models validation. 
 
In Chapter 5 (Results) we present the results of the samples selection and the performance of the models 
in both samples. 
 
In Chapter 6 (Discussion) the risk factors for obstructive sleep apnea (OSA) achieved on the univariate 
logistic regression are compared to the related on literature. The performance, advantages and 
disadvantages of the models are discussed. 
 
In Chapter 7 (Conclusions and recommendations) we expose a brief conclusion of our results and their 
explanations, as well as the main recommendations to apply these models on clinical practice 
 
In Chapter 8 (Future work) we explain the various possibilities to create a decision support system as in a 
sleep laboratory, based on ours models. 
 
 
 
 
 Prior Dissemination 
The investigation protocol to develop this thesis with the provisional tittle ''Data mining as an auxiliary 
diagnostic for the Syndrome of Obstructive Sleep Apnea: Is it possible to reduce the number of 
unnecessary polysomnographies?'', was shown on 4th Symposium on Medical Informatics, October 2011, 
Porto, Portugal 
 
The preliminary results was presented on the Intelligent Data Analysis meeting organized by the Health 
Information and Decision Sciences department, Faculty of Medicine, University of Porto, Portugal on 25th 
of January of 2012. 
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1. Introduction  
The syndrome of Obstructive Sleep Apnea (OSA) is a disease that affects approximately 4% of men and 
2% of women worldwide but is still underestimated and underdiagnosed (Al Lawati, Patel, & Ayas, 2009; 
Jennum & Riha, 2009; Madani & Madani, 2009; T. Young, Evans, Finn, & Palta, 1997). It is characterized 
by episodes of breathing cessation (apnea) or reduction in airflow (hypopnea) during sleep for at least 10 
seconds as a result of a upper airway collapse (Al Lawati et al., 2009; Iber C, 2007; Rechtschaffen, 1968; 
Redline et al., 2007; Silber et al., 2007). The severity of OSA is associated with the apnea-hypopnea index 
(AHI), documented during sleep, which can be divided into mild (5 ≤ AHI <15), moderate (15 ≤ AHI 
<30) and severe (AHI ≥ 30) ("Sleep-related breathing disorders in adults: recommendations for syndrome 
definition and measurement techniques in clinical research. The Report of an American Academy of Sleep 
Medicine Task Force," 1999).The standard method for assessing this index, and therefore defining the 
OSA diagnosis, is polysomnography (PSG). However, it is time-consuming, expensive and relativity 
limited to urban areas which, consequently, originates high waiting lists (Sun, Chiu, Chuang, & Liu, 2010).  
 
For a correct diagnosis, it is important to first determine the factors associated with the disease, and then 
use them to calculate the probability of the presence of OSA. According to the literature, the risk factors 
associated with OSA are age, gender and body mass index (BMI). However, there is no consensus on the 
weight of these factors in the prediction (Al Lawati et al., 2009; Davies, Ali, & Stradling, 1992; Doghramji, 
2008; Hoffstein & Szalai, 1993; Kapur, 2010; Kohler, 2009; Manber & Armitage, 1999; T. Young et al., 
1997; Terry Young et al., 2002; T. Young, Skatrud, & Peppard, 2004). Some authors referred other 
features such as neck circumference (NC), witnessed apneas or diurnal somnolence as important risk 
factors too (Davies et al., 1992; Pouliot, Peters, Neufeld, & Kryger, 1997). The path for a consensus is still 
undetermined. 
 
In Portugal, patients are referred by the primary care physician to a sleep consult, and then the sleep 
expert physicians decide the need to perform polysomnography. Although patients are screened by the 
physicians, based on clinical factors, the specificity of the entire process is rather low (48% of PSG 
performed in 2010, in our sleep laboratory, resulted negative for OSA, from which 75% had a completely 
normal result for sleep disorders) which, together with the limited availability of the service, yields long 
waiting lists both for consultation and to perform PSG. This problem is also prevalent in other sleep 
laboratories and several studies have been conducted to define the most important factors to determine 
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the probability of having OSA, and thereby reduce and optimize the number of patients that realize PSG, 
assigning different priority to patients (Al Lawati et al., 2009; Davies et al., 1992; Dixon, Schachter, & 
O’Brien, 2003; Flemons, Whitelaw, Brant, & Remmers, 1994; Gurubhagavatula, Maislin, & Pack, 2001; 
Hoffstein & Szalai, 1993; Maislin et al., 1995; Pouliot et al., 1997; Rodsutti, Hensley, Thakkinstian, D'Este, 
& Attia, 2004; Viner, Szalai, & Hoffstein, 1991; Terry Young et al., 2002). 
 
To identify more quickly OSA patients and possibly reduce the number of PSGs, some procedures have 
been adopted like the use of Portable Monitors (PM) and prediction models, but these don´t shows 
capable to stop the tendency of increased waiting lists. 
 
PM are a useful tool in cases of patients without comorbid conditions or medical disorders, with a higher 
probability of moderate or severe OSA. Otherwise, this method tends to underestimate severity of OSA, 
because don´t allow determine sleep efficiency, and so, PSG have to be performed on the most cases 
(Collop et al., 2007).  
 
Prediction models were built based on questionnaires and prediction methods to screen patients with a 
higher probability of OSA diagnosis (Flemons et al., 1994; Gurubhagavatula et al., 2001; Kaimakamis, 
Bratsas, Sichletidis, Karvounis, & Maglaveras, 2009; Kwiatkowska, Atkins, Ayas, & Ryan, 2007; Maislin et 
al., 1995; Pouliot et al., 1997; Sun et al., 2010; Viner et al., 1991). Traditionally, these models consisted in 
simple decision rules, the prognostic score and classification of patients into different risk categories. This 
score is often based on the combination of clinical variables and has been built for the general population, 
as well as for specific groups. These models can be an alternative method in a sleep consultation to help in 
the clinical decision to perform PSG. But, to construct clinical decision rules, we have to check some 
characteristics of the models to validate their use in clinical practice (Kononenko, 2001). The main 
limitation is sensitivity. These models need a high sensitivity, as false negatives should be avoided, to 
prevent excluding a patient with moderate or severe OSA from performing PSG. No study founded on 
literature in was fitted for 100% sensitivity. 
 
In Portugal, we found one study that tried to implement a screening tool for OSA. Vaz et al. used the 
Berlin Questionnaire (BQ), one of the most recognized screening tool, to screen patients with OSA in a 
sleep breathing clinic (Vaz et al., 2011). It includes 10 items organized in 3 categories concerning snoring 
and witnessed apneas (5 items), daytime sleepiness (4 items) and high blood pressure /obesity (1 item). 
Patients are also asked to provide information on age, gender, weight, height, neck circumference and 
ethnicity. Predetermination of high or lower risk for OSA is based on responses to each category of items. 
The authors achieve a sensitivity of 65.2 % and specificity of 80%, what reveals a good discrimination but 
poor performance in OSA identification. These results are similar to other studies that have different 
performances and don´t reveal BQ as an alternative to screen patients (Ahmadi, Chung, Gibbs, & Shapiro, 
 2008; Chung et al., 2008; Gami et al., 2004; Gus et al., 2008; Netzer, Stoohs, Netzer, Clark, & Strohl, 1999; 
Weinreich, Plein, Teschler, Resler, & Teschler, 2006). 
 
Another frequent problem in the application of the models is the lack of internal and/or external 
validation of the results (Davies et al., 1992; Flemons et al., 1994; Hoffstein & Szalai, 1993; Viner et al., 
1991; Terry Young et al., 2002) which compromises their application. Some studies don´t show the 
regression parameters (Hoffstein & Szalai, 1993; Terry Young et al., 2002); other use factors that are 
subjective and may lead to lower measurement reliability (Hoffstein & Szalai, 1993). Another point that 
limits their application is the choice of variables used in the construction of the models. As they are based 
on clinical variables, the missing of an important one compromises their results and, consequently, their 
validation. Neck circumference is one of the most significant clinical variable to identify patients with 
OSA according to some studies (Davies et al., 1992) but other studies don´t use this measure to construct 
their models (Pouliot et al., 1997; Rodsutti et al., 2004; Viner et al., 1991). Furthermore, the American 
Academy of Sleep Medicine (AASM) recommends the use of the 5 events per hour cutoff to distinguish 
patients with OSA from those where OSA is absent ("Sleep-related breathing disorders in adults: 
recommendations for syndrome definition and measurement techniques in clinical research. The Report 
of an American Academy of Sleep Medicine Task Force," 1999). Some studies used different cutoffs to 
describe OSA (10, 15, 20 or 30) which is questionable (Flemons et al., 1994; Hoffstein & Szalai, 1993; 
Maislin et al., 1995; Pouliot et al., 1997; Viner et al., 1991) and can introduce a large number of false 
negatives and difficulties in their comparison. 
 
Today, these models are generated by artificial intelligence, using decision trees, neural networks, support 
vector machines and Bayesian networks (BN) (Lee & Abbott, 2003; van Gerven, Taal, & Lucas, 2008). To 
be useful the models must have certain characteristics, such as good performance, good ability to handle 
data entry errors or omissions, transparency of diagnostic knowledge, ability to explain decisions, and the 
algorithm is able to reduce the number of tests needed for make a reliable diagnosis (Kononenko, 2001) 
 
Data mining involves the extraction of information, whose goal is to discover facts and / or unknown or 
hidden patterns in a database and extensive inference rules to predict trends. This process is based on 
combinations of machine learning and statistical analysis (Lavrac, 2001; Lee & Abbott, 2003; P. Lucas, 
2004; Mitchell, 1997; van Gerven et al., 2008). The data mining tools have been used in sleep medicine to 
create models alternative of those based in logistic regression like decision trees applied to PSG signals, 
genetic algorithm to screen patients with moderate or severe OSA.  
 
Bayesian networks, in particular, have been used in medical domain in some areas with high performance 
like in diagnoses of pneumonia and breast cancer, classification of cytological findings, classification, 
prediction of patient compliance to medication, prediction of clinician compliance to medical practice 
guidelines, prognosis of head injuries, determination of the risk factors of obesity, and pattern recognition 
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in narrative clinical reports (Aronsky & Haug, 2000; E. Burnside, Rubin, & Shachter, 2000; E. S. Burnside, 
2005; Hamilton et al., 1995; Lee & Abbott, 2003; Montironi, Bartels, Thompson, Scarpelli, & Hamilton, 
1995; Sakellaropoulos & Nikiforidis, 1999; Taktak, Ajmi Nabli, Ben Othmen, Mtiraoui, & Ben Hadj 
Hamida, 2011). As BN are a power data mining tool, we choose this method to create a model to screen 
patients with OSA. 
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2. Aim 
The main objective of this work is to define an auxiliary diagnostic method that can support the decision 
to perform polysomnography, or prioritize the waiting list to polysomnography, in patients recommended 
by a general practitioner, suspected of having OSA, specifically: 
• Prioritize patients recommended for PSG; 
• Reduce the number of ‘’unnecessary polysomnographies’’ (increase specificity) or give a higher 
priority in the waiting list for polysomnography to patients with more chances of OSA diagnosis; 
• Avoid the recommendation “unnecessary polysomnography” to OSA cases (avoid false 
negatives); 
• Produce effective models for use in clinical practice; 
• Expand the graphical interpretation of results. 
Background   6 
3. Background 
The upper airway includes the extrathoracic trachea, larynx, pharynx, nose and is separated into three 
regions: the nasopharynx, wich is defined from the nasal turbinates to the hard palate; the oropharynx, 
subdivided into the retro palatal region ; and the hypopharynx (Kryger, 2005). 
 
To study obstructive sleep apnea (OSA) we will focus on the pharyngeal airway, specifically the 
retropalatal retroglossal regions because is the site of upper airway closure or narrowing during sleep in 
the majority of patients with OSA. This part is a conduit for airflow connecting the nose with the larynx, 
pharyngeal patency is critical. With the exception  of the two ends of the respiratory airway tract (the nares 
and the small intrapulmonary airways), the pharynx is the only collapsible segment of the respiratory tract 
(Kryger, 2005). 
 
The sleep state is associated with a decrease in motor output to pharyngeal muscles. When this occurs 
against the background of upper airway anatomic abnormalities, severe narrowing or closure of pharyngeal 
airway can occur. 
 
3.1. Pathogenesis of OSA 
 
The pathogenesis of OSA may be explained by some factors: alterations of upper-airway dilator muscle 
activity during sleep and his anatomy, lung volume, ventilatory control stability, sleep state stability and 
rostral fluid shifts (Kapur, 2010; Yaggi & Strohl, 2010). The relationship of this factors influence breath 
and depends on a balance of forces: forces that promote airway collapse and opposing forces that 
maintain upper airway patency (Yaggi & Strohl, 2010). 
 
The balance of forces promoting airway collapse, like negative pressure of ventilation and extraluminal 
positive pressure, and forces to oppose these collapsing, activity of the pharyngeal dilator muscles (eg, 
genioglossus) and tensor pallitine dilator muscles are tonically active, are  usually maintained during sleep 
(Yaggi & Strohl, 2010) but, in patients with OSA, some of this controls are lost. Dilator muscle activity is 
controlled by geniouglossus, the muscle that forms the majority of the body of the tongue (Kapur, 2010; 
Yaggi & Strohl, 2010), and is responsible for stiffen and dilate various regions of the airway. Any 
 alterations in muscle activity or lower end-expiratory lung volume, increases the tendency of the upper 
airway collapse (Kapur, 2010). 
 
3.1.1. Ventilatory control stability 
 
OSA causes great instability of ventilatory control system and, consequently, a higher loop gain (measure 
of the stability of a negative-feedback control system) because autonomous system have to response to the 
inputs generated by the upper-airway muscles (Kapur, 2010). 
 
3.1.2. Stability of sleep 
 
The sleep stability is affected by the number increased of arousals that occurs as a biological response to 
the hypoxemia, causing an increase in respiratory effort and accentuate the changes in ventilation. Neural 
respiratory control centers response changing the level of PaO2 and PaCO2 augmenting and perpetuating 
respiratory cycling (Kapur, 2010; Yaggi & Strohl, 2010). 
 
3.1.3. Rostral fluid shifts 
 
Fluid displacement from the legs caused by lower body positive pressure, by inflation of antishock 
trousers increases neck circumference, narrows the pharynx, and increases collapsibility in awake healthy 
subjects has been shown to reduce upper-airway size and increase collapsity (Kapur, 2010; Yaggi & Strohl, 
2010). 
 
3.2. Sleep stages and event scoring 
 
The American Academy of Sleep Medicine (AASM) recommend the criteria scoring of sleep stages and 
the use of the terminology division into wakefulness, Non Rapid Eyes Movement (NREM) with 3 stages 
N1, N2 and N3, and REM (Rapid Eyes Movement)(Iber C, 2007; Silber et al., 2007). Table 1 summarizes 
the main characteristics of the five stages. 
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Table 1: Criteria for score sleep stages 
Stages Rules 
Wakefulness Eye blinks at a frequency of 0.52Hz 
Reading eye movements 
Irregular conjugate rapid eye movements associated with normal or high chin muscle tone 
Epochs without discernible alpha rhythm 
  
Stage N1  A. In subjects who generate alpha rhythm, score stage N1 if alpha rhythm is attenuated and 
replaced by low amplitude, mixed frequency activity for more than 50% of the epoch. 
B. In subjects who do not generate alpha rhythm, score stage N1 commencing with the earliest of 
any of the following phenomena: 
1) Activity in range of 4-7Hz with slowing of background frequencies by zl Hz from those of stage 
W. 
2) Vertex sharp waves. 
3) Slow eye movements. 
  
Stage N2:  A. One or more K complexes unassociated with arousals  
B. One or more trains of sleep spindles 
  
Stage N3  20% or more of an epoch consists of waves of 0.5-2 Hz frequencies with peak-to-peak amplitude 
of >75 µV in the frontal derivation. 
  
Stage R  
(REM sleep) 
Presence of eye movements are and stage 2 absent or low amplitude mixed frequency EEG and 
persistently low chin EMG tone 
REM: Rapid Eyes Movement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 According to the AASM, respiratory events can be divided into apnea or hypopnea (table 2). 
 
Table 2: Scoring of respiratory events 
Event Criteria 
Apnea Drop in the peak thermal sensor excursion of at least 90% of baseline 
During at least 10 seconds 
At least 90% of event’s meets the amplitude reduction criteria for apnea 
 Obstructive: Continued or increased inspiratory effort during the apnea 
 Central: Absence of inspiratory effort during the apnea 
 Mixed: Absence of inspiratory effort in the initial portion of the event followed by resumption of 
inspiratory effort in the second portion  
  
Hypopnea 
(Recommended 
rules) 
The nasal pressure excursions drop by ≥30% of baseline 
The duration of this drop is at least 10 seconds 
There is a ≥4% desaturation from pre-event baseline or the event is associated with arousal 
At least 90% of event’s meets the amplitude reduction criteria for hypopnea 
  
Hypopnea 
(Alternative 
rules) 
The nasal pressure excursions drop by ≥50% of baseline 
The duration of this drop is at least 1o seconds 
There is a ≥3% desaturation from pre-event baseline or the event is associated with arousal 
At least 90% of event’s meets the amplitude reduction criteria for hypopnea 
  
RERA Sequence of breaths during at least 10 seconds characterized by increasing respiratory effort or 
flattening of the nasal pressure waveform leading to an arousal from sleep when does not meet 
the criteria for apnea or hypopnea 
RERA: Respiratory effort-related arousal  
 
 
3.3. OSA diagnosis 
 
The diagnosis of OSA has to follow the criteria A or B plus C (Sleep-related breathing disorders in adults: 
recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American 
Academy of Sleep Medicine Task Force, 1999): 
 
A. Excessive daytime sleepiness that is not better explained by other factors; 
 
B. Two or more of the following that are not better explained by other factors: 
-choking or gasping during sleep, 
-recurrent awakenings from sleep, 
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-unrefreshing sleep, 
-daytime fatigue, 
-impaired concentration; and/or 
 
C. Overnight monitoring demonstrates five or more obstructed breathing events per hour during sleep. 
These events may include any combination of obstructive apneas/hypopneas or respiratory effort related 
arousals  
 
3.4. Severity levels of OSA 
 
Severity of the OSA has two components: severity of daytime sleepiness and of overnight monitoring. A 
severity level should be specified for both components. The rating of severity for the syndrome should be 
based on the most severe component ("Practice parameters for the use of portable recording in the 
assessment of obstructive sleep apnea. Standards of Practice Committee of the American Sleep Disorders 
Association," 1994): 
 
A. Sleepiness 
 
1. Mild: Unwanted sleepiness or involuntary sleep episodes occur during activities that require little 
attention. 
Symptoms produce only minor impairment of social or occupational function. 
 
2. Moderate: Unwanted sleepiness or involuntary sleep episodes occur during activities that require some 
attention. 
Symptoms produce moderate impairment of social or occupational function. 
 
3. Severe: Unwanted sleepiness or involuntary sleep episodes occur during activities that require more 
active attention.  
Symptoms produce marked impairment in social or occupational function. 
 
B. Sleep Related Obstructive Breathing Events  
 
1. Mild: 5 to 15 events per hour 
2. Moderate: 15 to 30 events per hour 
3. Severe: greater than 30 events per hour 
 
 
 3.5. Portable Monitors 
 
Based in the technology used or the signals that allows achieve, sleep studies are subdivided in 4 levels 
("Practice parameters for the use of portable recording in the assessment of obstructive sleep apnea. 
Standards of Practice Committee of the American Sleep Disorders Association," 1994) (Table 3) 
determinate through an evaluation of the evidence on portable monitors (PM) as an alternative to in-
laboratory polysomnography (PSG) (Collop et al., 2007). 
 
Table 3: Types of sleep studies used in sleep laboratories 
Type Characteristic 
1 Full attended polysomnography (≥ 7 channels) in a laboratory setting 
2 Full unattended polysomnography (≥ 7 channels) 
3 Limited channel devices (usually using 4–7 channels) 
4 1 or 2 channels usually using oximetry as 1 of the parameters 
 
Cardiorespiratory monitoring alone can also be used. This involves the measurement of airflow, 
respiratory effort, oxygen saturation and cardiac frequency, but not electroencephalography (EEG) (Type 
3 or 4). The great advantages of these systems are price, portability and the ability of patients to monitor 
themselves at home (Jennum & Riha, 2009) but they should always be performed only in conjunction with 
a comprehensive sleep evaluation. Although some studies of portable ambulatory type 3 or 4 monitoring 
reported a sensitivity of 78–100% and a specificity of 67–100% in comparison with in-lab PSG, 
ambulatory monitoring is of course not a gold standard. (Ferber et al., 1994) They have some important 
limitations and so, the PSG, still be considered as the gold- standard and be classified as type 1 of 
evidence. 
 
Overnight oximetry is sometimes used as a screening test for identifying patients who are at risk of 
significant OSA, but this should never be seen as a substitute for in-lab PSG or home cardiorespiratory 
monitoring. There are severe limitations inherent in this technique used in isolation, including the inability 
to detect apneas or hypopneas not associated with oxygen desaturation and the upper airway resistance 
syndrome (Jennum & Riha, 2009). 
 
The limitations of the PM are various. They can only be performed in patients with a high pretest 
probability of moderate to severe OSA without comorbid sleep or medical disorders when all of the 
previous parameters are met (Collop et al., 2007). In PM type 3 or 4 we don´t have access to the sleep 
stages and, consequently, we can´t calculate the apnea-hypopnea index (AHI) because we don’t know the 
total sleep time, and so we calculate the respiratory disturbance index (RDI) (that have a different 
12   Background 
 
definition on the PSG) that considers a number of events, scored as the same rules of the PSG, in the 
total record time. As result, are likely to underestimate the severity of OSA when compared with PSG 
because considers that the patient slept in all of the record, what can be false, and don´t allow associate 
the relationship between severity and sleep stage, in particular REM, that exacerbate many times the 
severity of the apneas and hypopneas (Flemons et al., 2003). 
 
3.6. Risk Factors 
 
3.6.1. Obesity  
 
Epidemiologic studies around the world have consistently identified body weight as the strongest risk 
factor for obstructive sleep apnea (Al Lawati et al., 2009; Punjabi, 2008). Excess body mass is associated 
with alterations in upper-airway structure through several distinct mechanisms including: (1) increased 
parapharyngeal fat deposition resulting in a smaller upper airway, (2) alterations in neural compensatory 
mechanisms that maintain airway patency, (3) respiratory control system instability, and (4) reduction in 
functional residual capacity with a resultant decrease in the stabilizing caudal traction on the upper airway 
(Madani & Madani, 2009; Punjabi, 2008; Stierer & Punjabi, 2005). 
 
Given that, the pathophysiology of obstructive sleep apnea is intimately linked with obesity an estimated 
58% of the moderate to severe cases attributable to a Body Mass Index (BMI) greater than/or equal to 
30Kg/m2 or higher (Doghramji, 2008). 
 
3.6.2. Neck and abdominal circumference  
 
Is frequently described that diameter of the neck and abdominal circumference is an important risk factor 
for OSA. Obesity / visceral obesity is the major risk factor for the development of OSA, because 
associated with anatomic alterations that predispose to upper airway obstruction during sleep and  
reduction in lung volume leads to an increase in pharyngeal collapsibility (Lam, Sharma, & Lam, 2010). 
 
Several studies have shown that the severity of OSA correlates with neck circumference, as a result of 
excess adipose tissue in the neck compressing the airway. A neck size of > 37 cm for women and 42 cm 
for men is generally accepted as clinically significant (Davies et al., 1992; Doghramji, 2008). 
 
3.6.3. Gender 
 
It is related that there is a much larger number of men affected by OSA than women. The ratio between 
men and women in clinical-based studies ranges from 2:1 to 9:1 according to various papers (Jennum & 
 Riha, 2009). There are several possible reasons for this disparity in sex difference ratio (Madani & Madani, 
2009).  
 
Hormonal differences are believed to account for the sex difference in OSA prevalence. Physiologic data 
suggest that the upper airway in women may be less collapsible than in men, a finding that has been 
attributed to female sex hormones (Stierer & Punjabi, 2005). 
 
Because sex hormone levels change with menarche, pregnancy and menopause, it is plausible that these 
changes modify the risk of OSA, most focus on menopause (Kapur, 2010; Lam et al., 2010; Madani & 
Madani, 2009; Manber & Armitage, 1999; Punjabi, 2008; Stierer & Punjabi, 2005). Pre-menopausal women 
seems protected from OSA even if they have other known risk factors for OSA (Lam et al., 2010). 
Furthermore, hormone replacement therapy in post-menopausal women has been associated with a lower 
prevalence in epidemiologic studies and some studies indicates that the prevalence of OSA is similar to 
premenopausal women (Lam et al., 2010; Madani & Madani, 2009). 
 
How women and men perceive and relate symptoms of sleep disorders breathing are reported too. If 
women are less likely to report classic symptoms like loud snoring, nocturnal snorting or gasping, and 
witnessed apneas, they are less likely to be referred to sleep clinics for evaluation (Punjabi, 2008; Yaggi & 
Strohl, 2010). 
 
In fact, analyses from different referral centers show that woman with obstructive sleep apnea have a 
greater tendency to report symptoms of fatigue and lack of energy than men. The different descriptions of 
OSA symptoms made by female or male bed partner are an important issue too. Female bed partners of 
male patients appear to have a lower threshold for symptom perception and reporting than male bed 
partners of female patients (Madani & Madani, 2009; Punjabi, 2008). 
 
There are sex-related differences in upper-airway anatomy and function, obesity and fat distribution and 
ventilator control. Men have increased fat deposition around the pharyngeal airway as compared with 
women. Other characteristics like larger tongue size in men’s than women’s, longer pharyngeal airway in 
men’s contributing to a predispose for an airway obstruction (Kapur, 2010; Madani & Madani, 2009; 
Punjabi, 2008). 
 
Finally, another hypothesis is the general expectation that the disorder predominantly affects men, takes 
health care providers to have a lower index of suspicion about the presence of OSA in women’s (Punjabi, 
2008). 
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3.6.4. Age 
 
Sleep characteristics changes during life. With advancing age, sleep quality decrease and sleep-related 
difficulties are more common, often manifested by complaints of difficulty falling asleep, increased 
number of night-time awakenings, a decreased amount of night-time sleep and lower arousal threshold 
(Madani & Madani, 2009; Yaggi & Strohl, 2010). Possible explanations for that include age-related changes 
in upper-airway caliber, attenuation in the ventilatory response to hypoxia and hypercapnia, decreases in 
functional activity of the upper airway, and an increase in the variability of ventilation during sleep. These 
changes increase deposition of fat in the parapharyngeal area, lengthening of the soft palate, and changes 
in body structures surrounding the pharynx, genioglossus negative pressure reflex seems to deteriorate 
with aging causing airway collapse (Lam et al., 2010; Madani & Madani, 2009; Yaggi & Strohl, 2010). 
 
This age-related variability in sleep stability contributes in some way to an increasing prevalence of OSA 
with advancing age. However, the existence of OSA in childhood, adolescence and older age means that 
there is no simple positive correlation of OSA with age (Jennum & Riha, 2009; Yaggi & Strohl, 2010). 
 
The 50-60 age group is the most frequently associated to the presence of OSA. The peak of age is 65 years 
old (Doghramji, 2008; Kapur, 2010; Madani & Madani, 2009; Yaggi & Strohl, 2010). 
 
3.6.5. Ethnicity 
 
This is a complex factor and several caveats should to be considered in the interpretation of the data 
linking race with an increased risk for OSA because many things can influence the results. One of the 
reasons is that populations with a higher prevalence of comorbid medical conditions, including obesity in 
conjunction with a low socioeconomic status and disadvantages in health care, could explain the higher 
prevalence of OSA apnea in this groups (Punjabi, 2008).  
 
Other factor can be the differences in craniofacial morphology. Despite lower levels of obesity, Asian 
samples seem to have a similar prevalence rate compared with the West when we are available ethnic and 
population differences. Asians have greater disease severity compared with whites. One possible 
explanation for such differences is in craniofacial morphology that are considered as the etiologic factors 
for the increased risk and greater severity of OSA in non-obese (Lam et al., 2010; Punjabi, 2008; Stierer & 
Punjabi, 2005; Yaggi & Strohl, 2010). Asians have soft tissue abnormalities, narrowed nasal cavities and 
tonsillar hypertrophy play an important role in the development of sleep apnea (Yaggi & Strohl, 2010; T. 
Young et al., 2004). 
 
 
 3.6.6. Craniofacial and upper-airway structure 
 
As referred above, craniofacial and upper structures are an important issue in the development of sleep 
apnea (Yaggi & Strohl, 2010; T. Young et al., 2004).  
 
Abnormal characteristics include enlarged tonsilis, enlarged uvula, “narrow airway”, macroglossia, 
retroplaced mandible, soft tissue, tonsillar hypertrophy, inferiorly positioned hyoid bone, and decreased 
posterior airway space can alter the mechanical properties of the upper airway and increase its propensity 
to collapse during sleep and promote the occurrence of apneas and hypopneas during sleep (Doghramji, 
2008; Lam et al., 2010; Madani & Madani, 2009; Punjabi, 2008; Stierer & Punjabi, 2005; Yaggi & Strohl, 
2010; T. Young et al., 2004). 
 
Mallampati scoring consists in a simple noninvasive method used to assess the difficulty of endotracheal 
intubation is very often used to identify craniofacial and upper-airway structure (Nuckton, Glidden, 
Browner, & Claman, 2006). 
 
3.6.7. Excessive daytime sleepiness 
 
Sleepiness can be regarded as ‘‘normal’’ sleepiness (a result of the normal circadian rhythm) and 
‘‘pathological’’ sleepiness (a result of altered sleep scheduling). Pathological sleepiness can be further 
subdivided into ‘‘habitual’’ (e.g. as the result of recurring precipitants of sleepiness such as OSA) or 
‘‘occasional’’ (e.g. as the result of jet lag or medication) (Jennum & Riha, 2009). 
 
Patients with OSA referred frequently daytime sleepiness in various situations. To evaluate daytime 
sleepiness in OSA the most widely questionnaire used to assess the likelihood of falling asleep in various 
situations and the best-validated scale is the Epworth Sleepiness Scale (ESS). The ESS consists in a 
questionnaire with 8 situations related to daily life and the subject is asked to score (on a 0 to 3 scale) how 
likely he/she doze off in these situations There is a maximal score of 24 and normal subjects score 
between 0 and 10. Scores greater than 10 is usually considered an indication of excessive day time 
sleepiness, greater than 12 suggest excessive sleepiness and further evaluation of OSA should be 
considered The advantages include ease of administration and low cost. It assesses global level of 
sleepiness and is independent of short-term variations in sleepiness with the time of day and also of inter-
day variations. The ESS is also able to discriminate between normal and pathological sleepiness. The 
accuracy of the ESS depends on the awareness of subjects falling asleep, which may not always be the case 
(Jennum & Riha, 2009; Johns, 1991). 
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Magnitude of daytime sleepiness associated with OSA was correlated with crash risk. Untreated OSA is a 
public risk because increase the risk of traffic accidents and their consequences (Al Lawati et al., 2009; 
Jennum & Riha, 2009). 
 
3.6.8. Genetics/Family history 
 
The risk factors listed earlier are also ‘‘complex’’ traits, and risk factors can operate either alone or in 
combination of many, genetic and family history are not an exception. 
 
The genetic influence is multifactorial rather than due to a single mutation or protein action and prohibit 
definitive conclusions on genetic underpinnings for OSA and that additional studies are needed to further 
define whether the disorder truly has a genetic component 
 
Some important characteristics such as craniofacial morphology, cephalometric abnormalities, including 
retroposition of the maxilla and mandible and a large soft palate, volume of the lateral parapharyngeal 
walls, tongue, soft tissue structures and other factors like self-reported sleepiness, ventilatory control and 
sleep cycles/ architecture  operating during sleep are in part the result of various genetic and 
environmental factors that act and interact to produce disease (Madani & Madani, 2009; Punjabi, 2008; 
Stierer & Punjabi, 2005; Yaggi & Strohl, 2010). Although the difficulty to define the genetic basis of 
obstructive sleep apnea, the available data suggests that inquiries about family history can certainly aid in 
identifying possible patients due to the familial susceptibility for sleep apnea seems to increase directly 
with the number of affected relatives (Punjabi, 2008). 
 
3.6.9. Smoking  
 
Airway inflammation and damage due to cigarette smoke could alter the mechanical and neural properties 
of upper airway and increase its collapsibility during sleep (Lam et al., 2010; Punjabi, 2008; Yaggi & Strohl, 
2010). Sleep instability, which has been linked to OSA, may be increased by overnight reductions in 
nicotine blood levels (Madani & Madani, 2009). Although the association with OSA is relatively weak, 
smoking may interact with and add to the cardiovascular risk associated with OSA (Yaggi & Strohl, 2010)  
 
3.6.10. Alcohol and sedatives 
 
Alcohol and sedatives ingestion can induce apneic activity in normal or asymptomatic individuals 
precipitate obstructive apneas and hypopneas during sleep (Punjabi, 2008) because relaxes upper airway 
dilator muscles and so  increases upper airway resistance resulting in hypotonia of the oropharyngeal 
muscles (Doghramji, 2008).  
 Therefore, alcohol intake can prolong apnea duration, suppress arousals, increase frequency of occlusive 
episodes and worsen the severity of hypoxemia (Lam et al., 2010; Madani & Madani, 2009).  
 
3.6.11. Comorbid conditions 
 
Obstructive sleep apnea also has been implicated in the etiology of comorbid and cardiovascular 
conditions, including hypertension, coronary artery disease, congestive heart failure, and stroke (Punjabi, 
2008). 
 
OSA is high in patients with hypertension and a casual role of OSA in hypertension has been suggested in 
several studies (T. Young et al., 2004). Some studies suggests that there are a potential relationship 
between OSA and stroke, however, this implication needs to be proved (Punjabi, 2008).   
 
The treatment of OSA can improve the conditions related above, and so, confirm the relationship 
between these conditions. Some medical conditions such as uncontrolled hypertension, coronary artery 
disease, congestive heart failure, stroke, and diabetes mellitus, undiagnosed obstructive sleep apnea should 
be considered as a possible concomitant problem. The reason maybe that intermittent hypoxemia and 
sleep disruption of obstructive sleep apnea are deleterious to glucose homeostasis and alleviating 
obstructive breathing during sleep with continuous positive airway pressure therapy has direct effects in 
improving hyperglycemia and improve the metabolic control (Punjabi, 2008). 
 
3.7. Diagnostic decision support  
 
The definition of clinical decision support systems is now a major topic since it may help the diagnosis, 
prognosis, and treatment selection. However, the complicated nature of real-world biomedical data has 
made it necessary to look beyond traditional biostatistics without loosing the necessary formality (P. 
Lucas, 2004). New computational techniques are better at detecting patterns hidden in biomedical data, 
and can better represent and manipulate uncertainties. For example, naive Bayesian approaches are closely 
related to logistic regression (Schurink et al., 2007). Bayesian approaches have an extreme importance in 
these problems as they provide a quantitative perspective, and allow taking into account prior knowledge 
when analyzing data, offering a general and versatile approach to capturing and reasoning with uncertainty 
in medicine and health care (P. J. F. Lucas, van der Gaag, & Abu-Hanna, 2004). 
 
3.7.1. Traditional clinical models 
 
When we have a dichotomous outcome, the technique of choice for statistical modeling is logistic 
regression (LR) (Tu, 1996). The relationship is achieve through the logistic regression equation, which 
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allows determine which explanatory variables influence the outcome and, consequently evaluate the 
probability that individual’s values of the explanatory variables, will have a particular outcome (Petrie & 
Sabin, 2009). The usual assumption is that these predictor variables are related in a linear manner to the 
log odds of the outcome of interest (Tu, 1996).  
 
Given the widely spend use of these models, more details are not present here. 
 
3.7.2. Beyond traditional statistics 
 
Actually, the health care services produce data that is increasing every day as a consequence of new 
techniques and the integration of data from different sources. The traditional statistics methods, like 
logistic regression, have been unable to deal with great databases, and so, the utilization of new methods, 
particularly machine learning ones, has been increasing. Data mining (DM) allows methods for data 
preprocessing and visualization, non-statistical methods and new methods based on probabilities and 
statistics that supports clinical decisions on models (P. Lucas, 2004). 
 
Artificial intelligence is a branch of computer science and machine learning is one of its subdivisions and, 
from the beginning, is used in medical databases. Tom Mitchell defines machine learning as ‘’the study of 
computer algorithms that improve automatically through experience. Successful applications range from 
data mining programs that discover general rules from large databases, to information filtering systems 
that learn users ‘reading preferences, to autonomous vehicles that learn to drive on public highways” 
(Mitchell, 1997). The three main branches of machine learning are statistical and pattern recognition 
methods like k-neighbors and Bayesian classifiers, inductive learning of symbolic rules like decision trees, 
decision rules or induction of logic programs and, finally, artificial neural networks (Kononenko, 2001). 
 
The Knowledge Discovery in large Databases process consists of five basic steps: (1) problem 
identification; (2) data extraction; (3) data preprocessing; (4) data mining, and; (5) pattern interpretation 
and presentation. The main tasks of data mining in healthcare may include (1) discovering associations, (2) 
clustering, or (3) creating predictive (classification/regression) models (Lee & Abbott, 2003). DM is 
concerned with finding patterns in large databases which are interesting and valid. There are numerous 
data mining algorithms that can be used in classification or prediction- predictive data mining algorithms, 
or finds associations, clusters- descriptive data mining algorithms (Lavrac, 2001). 
 
Decision support methods are built based in model selection that uses the best algorithm for a given 
dataset, and model integration/combination. They can provide an optimal solution and can be applied to 
build rules or decision trees proposing the best classifier for a given classification task. 
 
 In the healthcare/medical domain DM tools commonly used include neural networks, decision trees and 
Bayesian networks. Neural networks are designed to mimic the parallel processing ability of the human 
brain. Decision trees use a repeating series of branches that describes associations between attributes and a 
target variable. Bayesian networks provides a probabilistic approach (Lee & Abbott, 2003). 
 
To be applied in medical diagnostic tasks, machine learning based systems have to some requirements 
(Kononenko, 2001): 
1) Good performance: high values for diagnostic accuracy is crucial. The performance of most 
algorithms is at least equal to physicians.  
2) Dealing with missing data: In some patients records have lack of information, so, dealing with 
incomplete descriptions of patients is important. 
3) Dealing with noisy data: Uncertainty and errors are common in medical data. Therefore, ML 
applications must have effective means for handling noisy data. 
4) Transparency of diagnostic knowledge: the problem can be presented by the system in a different 
and new point of view, transparent to physician, not see before in an explicit form. 
5) Explanation ability: diagnosis must be presented in a clear way when diagnosis new patients.  
6) Reduction the number of tests: patient history has a large amount of data. The classifier must be 
able to reliably diagnose with a small amount of data about the patients.  
 
3.8. Bayesian Networks 
 
Bayesian networks (BN) are graph-based formalisms for the representation and manipulation of uncertain 
knowledge, based on probability theory. They provide a probabilistic approach to inference which allow 
taking into account prior knowledge when analysing data (P. Lucas, 2004; Mitchell, 1997). They are 
important to machine learning because they provide a quantitative approach to weighing the evidence 
supporting alternative hypothesis and represent a joint probability distribution and domain (or expert) 
knowledge in a compact way (Lee & Abbott, 2003; Mitchell, 1997). They consist of a qualitative and 
quantitative part. The qualitative part encodes, in a directed graph, the variables under study with their 
probabilistic interrelationships. The quantitative part is a set of conditional probabilities describing the 
strengths of the dependences between variables represented in the qualitative part. This parts together are 
sufficient to define a joint probability distribution on the statistical variables under study (Coupé & van 
der Gaag, 2002). 
BN are one of the most popular uncertainty formalisms because: they can handle noise, missing 
information and reveal probabilistic relations; possibilities learn from data and incorporate domain 
knowledge and provide a good interface through their compact graphical representation. Another 
advantage is that networks are flexible and the learned models can be used for many tasks like prediction 
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or diagnosis. One practical difficulty in applying Bayesian methods is that they typically require initial 
knowledge of many probabilities. A second practical difficulty is the significant computational cost 
required to determine the Bayes optimal hypothesis in the general case (Mitchell, 1997). 
For all the characteristics referred above and also that they are a powerful data mining technique for 
handling uncertainty in complex domains and a fundamental technique for pattern recognition and 
classification, the use of BN are increasing in the choice of data mining techniques applied  in medical 
domain (Lee & Abbott, 2003).  They allow the stepwise combination of prognostic evidence and provide 
a quantitative measure in terms of probabilities (Sakellaropoulos & Nikiforidis, 2000). 
 
3.8.1. Probabilistic reasoning  
 
To understand BN some basic probabilistic concepts have to be learned.  
If X  and Y  are random variables, with probability distributions             and            , the joint probability 
distribution         represents the distribution of both variables related. This way, for a given event           , 
the marginal probability of              , can be calculated: 
( ) ( ).,∑ ===
Y
YxXPxXP  
The conditional probability is a concept very important in medicine and is defined as an event             
given the occurrence of  
( ) .)(
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Given the properties of the joint distribution, the former equation can be rewriter as a famous theorem. 
The Bayes theorem provides a direct method for calculating the posterior probabilities of the various 
hypotheses given observations. More precisely, Bayes theorem provides a way to calculate the probability 
of a hypothesis ( )DhP |  based on its prior probability )(hP , the probability of observing various data given 
the hypothesis ( )hDP | , and the observed data itself (Mitchell, 1997), making it the cornerstone of Bayesian 
learning methods:  
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 In many scenarios, the learner is interested in finding the most probable hypotheses h  of a set of 
candidate hypotheses H given the observed data. The maximally probable hypothesis is called maximum a 
posteriori (MAP) hypothesis: 
( ) ( ).|maxarg hPhDPh
Hh
MAP
∈
=  
In other cases, we assume that every hypothesis in H is equally probable a priori. So, we just need consider 
the term ( )hDP | , called the likelihood of the data D  given h , to find the most probable hypothesis, and 
any hypothesis that maximizes ( )hDP |  is called a maximum likelihood (ML) hypothesis, MLh : 
( ).|maxarg hDPh
Hh
ML
∈
=  
The most probable classification of the new instance is obtained by combining the predictions of all 
hypotheses, weighted by their posterior probabilities. The Bayes optimal classification of the new 
instances jv  is described by (Mitchell, 1997): 
( ) ( ).||maxarg ∑
∈
DhPhvP iij
Vv j
 
The Bayes optimal classifier or Bayes optimal learner is every system that classifies new instances based in the 
equation above. 
When multiple dependences are stake, conditional independence is defined as a logic that supports 
symbolic reasoning about dependence and independence information, making it possible to abstract away 
from the numerical detail of probability distributions and the process of assessing probability 
distributions. 
Let X, Y, Z be sets of variables, X is conditionally independent of Y given Z if: 
( ) ).|(,| ZXPZYXP =  
This feature is the cornerstone of BN learning. 
 
3.8.2. BN: Definition, representation 
 
Bayesian network is a graphical representation of stochastic (statistical) dependences and independences 
among variables. The type of dependence and independence we are dealing with is determined by the 
direction of arcs and whether or not particular variables are instantiated. It is based on the assumption that 
the classification of patterns is expressed in probabilistic terms between predictors and outcome variables- 
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conditional assumption (Lee & Abbott, 2003). Clearly, the assumptions that are made in formulating this 
prior knowledge are crucial, and are a topic of much debate (P. Lucas, 2004). 
On the BN representation, graphical information is qualitative, nodes represents variables and arcs specify 
the (in) dependence between variables (Sakellaropoulos & Nikiforidis, 2000). In this way, each node is 
independent of all its non-descendent nodes, given its parents. This causes the joint probability 
distribution P is equivalent to the product of the (conditional) distributions (Sakellaropoulos & Nikiforidis, 
2000): 
( ) ( ).|,,,
1
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Where 
ix
pi is the set of parents of the vortex corresponding to the variable iX . 
So, A Bayesian network Β is defined as a pair ( )PG,=Β , where ( ) ( )( )GAGVG ,=  is an acyclic directed 
graph with a set of vertices (or nodes) ( ) { }nXXXGV ,,, 21 K=  and a set of arcs 
( ) ( ) ( )GVGVGA ×⊆ , and where P is a joint probability distribution defined on the variables 
corresponding to the vertices ( )GV . The basic property of a Bayesian network is that the joint 
distribution ( )nXXXP ,,, 21 K  is equivalent to the product of the (conditional) probabilities: 
( ) ( ).|,,,
1
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Thus,                      are the (conditional) probability distributions witch are specified for the variable iX , 
for ,,,1 ni K=  in creating a Bayesian network (Coupé & van der Gaag, 2002). 
 
3.8.3. Building BN 
 
The construction of a BN has two phases(Lee & Abbott, 2003): 
1. Creation of a BN structure: a acyclic graph which encodes probabilistic relationships among 
variables; 
2. Assessment of the prior and local conditional probabilities: training and testing the network 
structure. 
In contrast with logistic regression, where dependence and independence is hidden in approximating 
weights, in BN structure these are explicitly represented (Lee & Abbott, 2003). 
( )
iXi
XP pi|
 We can construct a BN manually or learn from data. Manual construction in practice are time consuming 
because requires access of human experts. Learning from data in nowadays are much more attractive, 
consequence of the increasing of clinical and biological data (P. J. F. Lucas et al., 2004).  
The manual way comprehends various stages using the expert knowledge, relevant literature and analysis 
of available patient data (P. J. F. Lucas et al., 2004). The five main stages are: 
1. Selection of relevant variables: is generally based on interviews with experts, descriptions of the 
domain and an extensive analysis of the purpose of the network under construction. 
2. Identification of the relationships among the variables: determine how those factors are related to 
each other. Dependence and independence relationships between them have to be analysed and 
expressed in a graphical structure. Causal graph, common effects and causes. 
3. Qualitative probabilistic and logical constrains: qualitative probabilistic derived from properties of 
stochastic dominance of distributions. Logical constrains are derived from functional relationship 
between the variables. 
4. Assessment of probabilities: Local conditional probability distributions Pr (Xi|pi(Xi))  for each 
variable Xi are filled in. The required probabilities can be obtained from domain experts or, 
alternatively, from data. 
5. Sensitivity analysis and evaluation: to be used in real-life practice, BN are tested and evaluated.  
One way to assess network’s quality is to perform a sensitivity analysis with patient data. There 
are various ways to evaluate BN like measuring classification performance on a given set of real 
patient data and measuring similarity of structure or probability distribution to a gold-standard 
network or other probabilistic model. 
 
3.8.4. Learning BN from data 
 
BN can be learnt from data without explicit access to knowledge of human experts by exploring various 
issues such as comparison of learning algorithms, dealing with missing data and evaluation of the 
networks learned (P. J. F. Lucas et al., 2004). 
To create BN from data with learning purpose this have to satisfy some requisites: data collection is very 
important to avoid bias that interfere in the BN impact and purpose; data’s variables and values should 
match characteristics to be modelled in the network or should at least admit easy translation; the size of 
the data have to allow reliable information of probabilistic relationships among variables discerned; must 
have properties that allows the use of the most learning algorithms.  
 
One important aspect is that many statistical and learning methods cannot deal with missing values and 
the absence of missing values has to be ensured by two ways: removing the cases with missing data or 
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filling (imputing) missing data. The first method has to be applied with caution as it can result in the loss 
of a large amount of valuable data, thus leading to a decrease in the robustness of the models learned. The 
second one means that the missing value is replaced with an estimate of the actual value (P. J. F. Lucas et 
al., 2004).  
 
Learning Bayesian networks involves both structure learning, i.e., learning the graph topology from data, 
and parameter learning, i.e., learning the actual, local probability distributions from data. There are 
basically two approaches to structure learning: search and score structure learning, and constraint-based 
structure learning. 
 
Search-and-score algorithms search for a BN structure that fits the data best (in some sense). These 
methods search the space of all possible acyclic digraphs by generating various different graphs in a 
heuristic way and comparing these to their ability to explain that at hand. They start with an initial network 
structure (often a graph without arcs or a complete graph), and then traverse the search space of network 
structures by in each step removing an arc, adding an arc, or reversing an arc. Recent search-and-score-
algorithms take Markov equivalence into account, i.e., they search in the space of equivalence classes of 
Bayesian networks and the scoring method they use give the same score for equivalent networks. Bayesian 
networks with different graph topologies that are included in the same Markov equivalence class represent 
exactly the same conditional-independence information by d-separation. Examples of search and score 
algorithms are K2 and inclusion-driven learning. They usually are based on hill climbing (greedy) search (P. 
J. F. Lucas et al., 2004). K2 performs a greedy search that trades off network complexity for accuracy over 
the training data (Mitchell, 1997). 
 
Constraint-based algorithms carry out a conditional (in) dependence analysis on the data and allow for the 
easy incorporation of background knowledge, i.e., prior knowledge on dependences or independences that 
hold for the domain under consideration. Examples of constraint-based learning algorithms are PC, NPC, 
growshrink, and incremental association (P. J. F. Lucas et al., 2004).  
 
3.8.5. Naïve Bayes classifier 
 
The naïve Bayes (NB) classifier is based on the simplifying assumption that the attribute values are 
conditionally independent given the target value (Mitchell, 1997): 
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 One interesting difference between the naïve Bayes learning methods and other learning methods is that 
there is no explicit search through the space of possible hypothesis (Mitchell, 1997). Naïve Bayes is robust 
to the presence of irrelevant attributes(but redundant variables must be taken into account, as they have 
impact on performance), the variability of a data set is summarized in contingency tables and the 
dimension of the decision model is independent of the number of examples. 
The general structure of a naïve Bayesian network is shown of figure 1. 
 
Figure 1: Naive Bayes networks 
F represents the features variables and C the class variable  
 
3.8.6. Tree augmented Bayesian network  
 
Tree augmented Bayesian network (TAN) is an extension of naïve Bayes: reducing the number of 
independent assumptions, each node has at most two dependences, one conditionally from the class and 
other conditionally from other attribute (P. J. F. Lucas et al., 2004) (figure 2). 
 
Figure 2: Tree augmented Bayesian network 
 F represents the features variables and C the class variable  
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TAN computes the Mutual Information between all pairs of variables given the class to define the 
network structure: 
( ) ( ) ( )∑ ==
c
cCYXcPCYXI .|,/|,  
 
3.8.7. Probabilistic inference  
 
If a new case is inserted in the BN, new evidence is introduced to the BN which causes an update of the 
belief in various prognostic outcomes. System calculates the posterior probability of the outcomes, given 
the specific evidence. This process is called inference and BN are used with this function (Sakellaropoulos 
& Nikiforidis, 2000). It means that we can infer the value of some target variable given the observed 
values of other variables using BN. 
In general, a BN can be used to compute the probability distribution for any subset of network variables 
given the values or distributions for any subset of the remaining variables. What we need to infer is the 
probability distribution for the target variable, which specifies the probability that it will take on each of its 
possible values given the observed values of the other variables(Mitchell, 1997). 
 
3.9. Performance measures in classification problems 
 
To improve performance, determinate an appropriate sensitivity-specificity trade-off, through applying 
different algorithms and parameters is crucial (Lavrac, 2001). The performance and quality of predictive 
models should be evaluated by their abilities of discrimination and calibration (Dreiseitl & Ohno-
Machado, 2002; Lee & Abbott, 2003) 
Discrimination measures how much the model is able to separate cases with positive outcome value from 
those with negative outcome value. Calibration is a measure of how close the predicted values are to the 
real outcomes, measuring whether they are high or low when compared to the real outcomes (Dreiseitl & 
Ohno-Machado, 2002; Lee & Abbott, 2003). 
The most commonly used measures of discriminatory power are the area under the ROC curve (AUC), a 
plot of the sensitivity versus specificity of a model in a binary classification task sensitivity, specificity, and 
accuracy (Dreiseitl & Ohno-Machado, 2002; Lee & Abbott, 2003). Calibration of the models can be 
measured by construction of calibration curve or computation of the Hosmer–Lemeshow goodness- of-fit 
v2 statistic (Lee & Abbott, 2003).  Sensitivity is defined as the number of correctly classified cases as 
positives divided by the total number of actual positive cases. Specificity is defined as the number of 
 correctly classified cases as negatives divided by the total number of actual negative cases (Lee & Abbott, 
2003).  
As each sensitivity and specificity are reported for a single threshold point, the ROC curve can be plotted 
through various cut-off values. AUC gives a definitive measure of the classifiers discrimination ability that 
is not dependent on the choice of cutoff point value and so represents a measure of sensitivity and 
specificity over all possible thresholds (Dreiseitl & Ohno-Machado, 2002; Lee & Abbott, 2003). 
On health domain the false alarm rate, specificity, needs to be minimized, and the detection rate, 
sensitivity, which needs to be maximized (Lavrac, 2001). 
Accuracy, calculated using a threshold closest to (0, 1) that minimizes the sum of (1- sensitivity) 2 and (1-
specificity) 2, is the only discrimination measure influenced by the class distribution in the data set. Aware 
when the case distribution in the training set is different from the case distribution of the population on 
which the classifier is used (Dreiseitl & Ohno-Machado, 2002; Lee & Abbott, 2003).  
Positive predictive value (PPV) and negative predictive value (NPV) cannot be ignored in reporting the 
results. PPV is the proportion of cases that the network classifies as positive that actually are positive, and 
NPV is the proportion of cases that the net classifies as negative that are actually negative (Lee & Abbott, 
2003).  
To provide an unbiased estimate of a models discrimination and calibration, these values have to be 
calculated from a data set not used in the model building process. Usually, the original data set is split into 
test or validation set, and training set to avoid overffiting. There are many ways to evaluate models 
performance; we will numerate only cross-validation and bootstrapping. On the cross-validation process 
n-fold cross-validation builds n models; the numbers reported are the averages over all n test sets, learning 
is done on subsequent parts of the data not used in the train process. The extreme case of using only one 
data item for testing is known as leave-one-out cross-validation. An alternative to cross-validation is 
bootstrapping, a process by which training sets are sampled with replacement from the original data sets 
(Dreiseitl & Ohno-Machado, 2002; Lavrac, 2001). 
 
 
 
Material and Methods    28 
 
4. Material and Methods 
A literature review was performed to define the relevant variables to be collected. Data was prospectively 
collected from patients in two periods of time. A logistic regression (LR) and Bayesian networks (BN) 
models were built. Results from polysomnography (PSG) were categorized into normal or obstructive 
sleep apnea (OSA) (independently of the severity) and results were validated to improve the generalization 
of the model using cross-validation (CV). Finally, we apply the final models, LR and BN, on the second 
comparable cohort. 
 
4.1. Variables 
 
The selection of variables were based in a literature search on Pubmed on 27th of September of 2011, 
using Mesh terms “risk factors”, “obstructive sleep apnea” and “diagnosis”. We obtained 442 articles and 
we selected only reviews to determine the variables to our study. At the first search we found 127 re views 
and excluded 96 articles after read the title and abstract because they studied children, pregnant, OSA as a 
secondary problem from another disease, only about women or elderly, or were not related to risk factors. 
Of the 48 full text required, we excluded 17 because 6 we didn´t had access in time, the others weren´t 
about risk factors, language not Portuguese or English or were about OSA as a resultant disease. From the 
bibliography of these articles we included one article, finishing our search with 32 articles. 
 
The 33 collected and studied variables were considered from 32 articles and are presented in table 4 
(Berry, 2008; Bonekat & Hardin, 2003; Doghramji, 2008; Epstein et al., 2009; Fogel & White, 2000; 
Jennum & Riha, 2009; Kapur, 2010; Krieger & Redeker, 2002; Krug, 1999; Kuhlmann, Bormann, & 
Becker, 2009; Lam & Ip, 2010; Lam et al., 2010; Madani & Madani, 2009; Olson, Park, & Morgenthaler, 
2005; Pagel, 2008; Palmer & Redline, 2003; Park, Ramar, & Olson, 2011; Pillar & Lavie, 2011; Punjabi, 
2008; Schwab, 2005; Sheldon, Belan, Neill, & Rowland, 2009; Stierer & Punjabi, 2005; Tasali, Mokhlesi, & 
Van Cauter, 2008; Tate & Tasota, 2002; Togeiro et al., 2010; Yaggi & Strohl, 2010; Younes, 2003; T. 
Young et al., 2004). 
 
 
 Table 4: Variables collected in the studied patients  
Demographic Physical Examination 
       Gender        Body Mass Index  (BMI) 
       Ethnicity        Neck circumference (NC) 
       Age        Abdominal circumference (AC) 
        Craniofacial and upper airway abnormalities 
  
Clinical history Comorbidities and other conditions 
       Snore        Atrial fibrillation 
       Witnessed apneas        Stroke 
       Gasping/Shocking        Myocardial infarction 
       Motor Vehicle Crashes        Pulmonary hypertension 
       Refreshing Sleep        Congestive heart failure 
       Humor alterations        Diabetes 
       Nocturia        Metabolic Syndrome 
       Restless Sleep        Renal failure 
       Decreased libido        Hypothyroidism 
       Morning Headaches        Gastroesophageal reflux  
       Alcohol before sleep        Hypertension 
       Smoker  
       Sedative use  
       Epworth Somnolence Scale (ESS)  
       Concentration decrease  
 
4.2. Patients 
 
This study included the patients referred to perform PSG at the Sleep Laboratory of Vila Nova de 
Gaia/Espinho Hospital Center, Portugal. We collected two samples with patients that agreed to 
participate in the study, one for the development of the models and a second one to test the proposed 
models. The first sample includes patients that realized PSG between December of 2011 to February of 
2012 and the second between April and May of 2012. All adults, older than 18 years, referred by the 
physicians with suspected OSA and agreed to participate in the study, were included. In case of duplicate 
studies (sometimes the patient repeats the test), the one with best sleep efficiency was selected. Patients 
with suspicion of another disorder than OSA, patients already diagnosed (therapeutic studies), and 
patients with severe lung disease or neurological condition that somehow affects the respiratory function, 
such as neuromuscular diseases, were excluded. 
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This study was approved by the Ethics Commission of Centro Hospitalar de Vila Nova de Gaia/Espinho, 
Portugal and patients were not exposed to any adverse effects. 
 
4.3. Data collection 
 
Clinical information was collected prospectively during consultation, 3 months before PSG. However, all 
variables were checked to avoid missing information and if some variable was missing it would be 
collected during PSG. During PSG the parameters, settings, filters, technical specifications, sleep stage, 
event scoring and final results were applied according to the American Academy of Sleep Medicine 
(AASM) rules (Iber C, 2007). 
 
To achieve cerebral activity, we used a combination of parameters including EEG, electro-oculography 
(EOG) and electromyography (EMG). The EEG derivations were C4-M1, O2-M1, C3-M2 and O1-M2. A 
thermal flow was used to score apneas, a nasal air pressure device to identify hypopneas, a snore sensor 
for snoring, one derivation for electrocardiography (ECG), chest and abdominal belts to evaluate 
respiratory effort, position sensor, leg EMG and pulse oximetry. 
 
Hypopneas were scored if the nasal pressure signal excursions drop by ≥ 30% of baseline and duration of 
this drop was at least 10 seconds with a ≥4% desaturation from pre-event baseline (recommended rules of 
AASM). 
 
Data quality was checked and validated before analysis to avoid duplicate records and errors on data.  
 
For this study, the outcome measure is the clinical diagnosis supported on PSG results, categorized into 
normal or OSA (mild, moderate and severe). 
 
4.4. Logistic Regression model 
 
Odds ratios (OR) and respective 95% confidence intervals were calculated using univariate LR for the 33 
variables as independent variables and the presence of OSA as dependent variable. The independent 
variables with significant OR were used in the multiple forward conditional logistic regression analysis to 
construct the model. A significance level of 5% was used. 
 
Receiver Operating Characteristic (ROC) curve analysis was performed to determine prediction error and 
AUC to achieve the cutoff for our model. The target sensitivity is 100%, to avoid false negatives, yet 
aiming at reducing the number of unnecessary exams (increasing specificity), but we also tested our results 
aiming a 95% of sensitivity. 
 4.5. Bayesian Network model 
 
Models were built using only the significant variables achieved on the univariate LR. First, we made a pre-
processing of the data. Missing data was removed and continuous variables Body Mass Index (BMI), Neck 
circumference (NC) and Abdominal circumference (AC) were categorized into dichotomous variables: 
BMI into normal or obese, NC and AC into normal or increased, according to the literature (Direcção 
Geral da Saúde, 2012; Davies et al., 1992) (table 5). 
 
Table 5: Parameters used to recode continuous variables BMI, NC and AC into dichotomous 
 
 Male Female 
Body Mass Index (BMI)   
       <30 Normal Normal 
       ≥30 Obese Obese 
Neck Circumference (NC)   
      ≤37 Normal Normal 
      37-42 Normal Increased 
      >42 Increased Increased 
Abdominal Circumference (AC)   
      ≤80 Normal Normal 
      80-94 Normal Increased 
      ≥94 Increased Increased 
 
To see the relationship among the six variables we build a network without any class information. 
 
The result of PSG (normal or OSA) was defined as the label attribute to construct the models.  
 
The Bayesian networks (BN) classifiers used to build the models were Naïve Bayes (NB) and Tree 
Augmented Bayesian Network (TAN), given their previous good results in other clinical domains (E. 
Burnside et al., 2000; Montironi et al., 1995; Sakellaropoulos & Nikiforidis, 1999). Different cutoffs were 
used to achieve two levels of sensitivity: 100% and 95%. 
 
We use R to learn a network without labelling the examples, using the package BNLEARN, which 
provides a free implementation of some BN structure learning algorithms (Scutari, 2010). Rapidminer was 
used to build and evaluate NB and TAN performance and check conditional probabilities given the class 
outcome of PSG (normal or OSA). Finally, SamIam was used to inspect and consult the BNs. 
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4.6. Models validation 
 
We use the results of sensitivity and specificity to determine the performance of our models and choose 
different thresholds, accordingly. 
 
The LR model was evaluated with sensitivity and specificity estimates on train data, and using 10 times 2-
fold cross validation to check for external validation. All the analysis was performed with SPSS statistical 
software (SPSS, Inc, Chicago, IL, USA). To evaluate the BN performance models we used leave-one-out 
CV. 
 
An external validation was made applying the final models, LR and BN, on a second comparable cohort. 
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5. Results 
5.1. Patients 
 
On the first data collection, used to create the logistic regression (LR) and Bayesian networks (BN) 
models, from the 113 patients considered for inclusion, 27 were excluded for several reasons depicted in 
figure 3. We collected data from 86 patients, 69 (80%) of which were male and mean age was 56 years. 
Forty one patients (48%) had normal result with age mean of 54 years; of the 45 patients with obstructive 
sleep apnea (OSA) (52%), 17 (37%) were categorized into mild, 15 (33%) were moderate and 13 (30%) 
were severe, and the mean age was 57 years (table 6). 
 
 
 
Figure 3: Flow diagram for inclusion of patients in the study 
 
The analysis of univariate regression showed 6 variables (table 6) with significant odds ratio (OR): male 
gender (OR=7.259, 95% CI=[1.096; 27.651]), body mass index (OR=1.159, [1.030; 1.303]), neck 
circumference (OR=1.341, [1.159; 1.550]), abdominal circumference (OR=1.076, [1.025; 1.129]), 
witnessed apneas (OR=4.725, [1.772; 12.599]) and alcohol before sleep (OR=3.307, [1.350; 8.100]). 
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Table 6: Description and odds ratios for the 33 studied variables  
 Normal (n=41) OSA (n=45) Simple OR 95%CI 
Gender, n (%)     
Male 27 (66) 42 (93) Ref.  
Female 14 (34) 3 (6) 7.259 [1.096;27.651] 
Ethnicity, n (%)     
European 40 (98) 44 (98) - - 
African 1 (2) 1 (2) - - 
Age, mean (sd) 54 (14) 57 (13) 1.020 [0.988;1.052] 
Snore, n (%) 41 (100) 45 (100) - - 
Witnessed apneas, n (%) 20 (49) 36 (82) 4.725 [1.772;12.599] 
Gasping/Shocking, n (%) 7 (17) 14 (31) 2.194 [0.783;6.142] 
Motor Vehicle Crashes, n (%) 3 (8) 3 (7) 0.872 [0.165;4.608] 
Refreshing Sleep, n (%) 17 (41) 22 (49) 1.350 [0.575;3.169] 
Humor alterations, n (%) 2 (5) 2 (4) 0.907 [0.122;6.751] 
Nocturia, n (%) 16 (39) 16 (36) 0.862 [0.359;2.069] 
Restless Sleep, n (%) 4 (10) 9 (20) 2.312 [0.653;8.185] 
Decreased libido, n (%) 0 (0) 1 (2) - - 
Morning headaches, n (%) 10 (24) 8 (18) 0.670 [0.236;1.906] 
Alcohol before sleep, n (%) 12 (29) 26 (58) 3.307 [1.350;8.100] 
Smoker, n (%)     
             No 22 (54) 25 (56) Ref.  
             Yes 10 (24) 7 (16) 0.616 [0.200;1.894] 
             Ex-smoker 9 (22) 13 (29) 1.27 [0.456;3.543] 
Sedative use, n (%) 8 (18) 9 (20) 1.031 [0.356;2.986] 
ESS, median (range) 8 (19) 8 (24) 0.980 [0.908;1.050] 
Concentration decrease, n (%) 8 (19) 3 (7) 0.295 [0.072;1.198] 
BMI, mean (sd) 28 (4) 30 (5) 1.159 [1.030;1.303] 
NC, mean (sd) 39 (3.4) 43 (3.8) 1.341 [1.159;1.550] 
AC, mean (sd) 100 (10) 108 (12) 1.076 [1.025;1.129] 
Craniofacial and upper airway abnormalities, n (%) 17 (41) 28 (62) 2.325 [0.979;5.526] 
Atrial fibrillation, n (%) 1 (2) 1 (2) 0.909 [0.055;15.020] 
Stroke, n (%) 1 (2) 2 (4) 1.860 [0.162;21.319] 
Myocardial infarction, n (%) 4 (9) 2 (4) 0.430 [0.075;2.484] 
Pulmonary hypertension, n (%) 0 (0) 0 (0) - - 
Congestive heart failure, n (%) 1 (2) 0 (0) - - 
Diabetes, n (%) 8 (19) 9 (20) 1.031 [0.356;2.986] 
Metabolic Syndrome, n (%) 0 (0) 0 (0) - - 
Renal failure, n (%) 0 0 - - 
Hypothyroidism, n (%) 3 (7) 0 - - 
Gastroesophageal reflux disease, n (%) 2 (5) 3 (7) 1.393 [0.221;8.783] 
Hypertension, n (%) 21 (51) 22 (49) 0.911 [0.391;2.124] 
BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference; ESS: Epworth Somnolence Scale; OR: Odds 
Ratio; CI: Confidence Interval 
 5.2. Logistic Regression Model 
 
A multiple forward conditional logistic regression analysis was created with neck circumference (NC), 
gender, witnessed apneas (WA) and consume of alcohol before sleep. Abdominal circumference (AC) and 
body mass index (BMI) variables were not considered for this model given their high co-linearity with the 
strongest variable, NC. After two steps, NC and WA were the final variables present in the equation of 
the multivariate regression, with intercept -11.147 and coefficients 0.256 (OR=1.292) and 1.134 
(OR=3.108), respectively. 
 
The ROC curve (fig. 4) analysis demonstrated an AUC of 80%, with a confidence interval (CI) of [70%; 
89%]. Given the good discriminative power of the model, a cutoff value of 10% (patients with probability 
of OSA higher than 10% were recommended PSG) was chosen to achieve a sensitivity of 100% [92%; 
100%] and a specificity of 5% [1%; 15%]. However, aiming at a not so strict value for sensitivity, we could 
get better results for specificity. Actually, with a cutoff value of 25%, a sensitivity of 95% [86%; 99%] and 
specificity of 35% [22%; 50%] were achieved. Inspecting erroneous classifications with the cutoff value of 
25%, the two misclassified OSA patients were actually diagnosed with mild OSA (representing 12% of 
total mild OSA patients). For the 10% cutoff value the cross-validation results were 98±3% sensitivity and 
11±3.5% specificity, while for the 25% cutoff value the resulting sensitivity was 89±4% and 34±7% for 
specificity. 
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Figure 4: ROC curve of the model 
 
5.3. Bayesian Networks 
 
Figure 5 represents the Bayesian network and the conditional probabilities of the 6 significant variables 
with significant OR achieved on univariate LR, male gender, NC; AC, WA and alcohol before sleep, 
created with no class information. 
 
  
Figure 5: Bayesian network and the conditional probabilities 
 (WA: Witnessed Apneas, BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference) 
As we found on multiple LR, there is a high association between AC, BMI and NC. BMI influences NC 
and AC, with certain that an obese have AC increased and a higher probability of have a NC increased, 
P(NC|Obese)=0.84, when compared with not obese, P(AC|¬Obese)=0.85 and P(NC|¬Obese)=0.19. 
 
NC influences OSA and alcohol before sleep. There is a high probability that a patient has OSA given 
having NC increased, P(OSA|NC)=0.75, when compared with an NC normal, P(OSA|¬NC)=0.34. 
 
OSA influences gender, with a high probability of a male having OSA diagnosis, P(Male|OSA)=0.93 and 
lower to be normal, P(Male|¬OSA)=0.65. Of course caution is advised in interpreting such dependences 
as causation. 
 
Gender influences WA and alcohol before sleep, with the presence of these two variables more likely in 
men, P(WA|Male)=0.74 and P(Alcohol|Male)=0.36 than in women P(WA|Female)=0.29 and 
P(Alcohol|Female)=0.09 
 
 
 
P(Male|OSA)=0.93 
P(Male|¬OSA)=0.65 
P(NC|Obese)=0.84 
P(NC|¬Obese)=0.19 
P(Alcohol| Male)=0.36 
P(Alcohol|Female)=0.09 
P(WA|Male)=0.74 
P(WA|Female)=0.29 
P(OSA|NC)=0.75 
P(OSA|¬NC)=0.34 
P(Obese)=0.37 
P(AC|Obese)=1.00 
P(AC|¬Obese)=0.85 
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5.3.1. Naïve Bayes network classifier 
 
Figure 6 shows the NB based model with the outcome of PSG as label attribute. 
 
 
Figure 6: Naive Bayes classifier  
(BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference) 
 
Aiming 100% of sensitivity, we achieve 7% as cutoff for NB, obtaining a sensitivity of 100% and 25% for 
specificity while using a higher cutoff of 10%, for 95% of sensitivity, the results were 98% and 33% for 
sensitivity and specificity respectively, for internal validation (table 8). 
 
The same cutoffs were used on leave-one-out cross-validation (CV) to check the external validation of 
NB. Using 7% as cutoff, the results were 98% for sensitivity and 18% for specificity, while using the 10% 
cutoff the results were 93% to sensitivity and 30% for specificity (table 8). 
 
The marginal probabilities if no information is given to the network are shown on figure 7.  
 
 
 
  
Figure 7: Marginal probabilities of Naïve Bayes classifier to the presence of OSA  
(BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference) 
 
5.3.2. Tree Augmented Bayesian network 
 
The tree augmented Bayesian network (TAN) model is shown in figure 8. 
 
 
Figure 8: Tree augmented Bayesian network 
(WA: Witnessed Apneas, BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference) 
One more time, as we saw on NB and LR, we verify high association between AC, NC and BMI. Only 
three variables have one more dependence beyond the class variable outcome: alcohol and WA are 
influenced also by gender, as we saw in the network without class information, and gender is influenced by 
AC.  
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As we did to NB, we tested different cutoffs to achieve different levels of sensitivity and specificity. For a 
100% of sensitivity we choose 2% as cutoff and for 95% of sensitivity we achieve a cutoff of 22%. As 
internal validation results, the model with 2% cutoff had a sensitivity of 100% and 28% to specificity and 
using a higher cutoff of 22%, the results were 95% and 38% for sensitivity and specificity respectively 
(table 8). 
 
On leave-one-out CV, to check the external validation, using the same cutoffs described above, the 2% 
cutoff has 88% for sensitivity and 23% for specificity while the higher cutoff had 84% of sensitivity and 
25% for specificity (table 8). 
 
The marginal probabilities of TAN are presented on figure 9.  
 
 
Figure 9: Marginal probabilities of TAN 
(WA: Witnessed Apneas, BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference) 
 
5.4. Validation on a second comparable cohort 
 
To test the performance of the model in clinical practice, we collected a second cohort with 33 patients 
(fig. 10). 
 
 
 
 
 
 
 
  
Figure 10: Flow diagram for inclusion of patients in the second comparable study 
As we expected, there was a higher value for normal results (45%), mainly male gender (76%), with mean 
age of 53 years (table 7). Of the 18 patients with OSA (54%), 6 (33%) were categorized into mild, 7 (39%) 
were moderate and 5 (28%) were severe. Statistical testing (table 7) showed that the two cohorts are 
comparable with respect to the main studied variables (OSA, gender, witnessed apneas, alcohol before 
sleep, BMI, NC and AC). 
 
Table 7: Characteristics of two samples 
 
*-Chi-square test      **-Fischer test  ……***-t test 
OSA: Obstructive Sleep Apnea; BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference; BMIr: Body 
Mass Index recoded; NCr: Neck circumference recoded; ACr: Abdominal circumference recoded. 
 
 
 Test Train p 
 N=33 N=86  
OSA, n (%) 18(55) 45(52) 0.833* 
Gender, n (%)   0.634* 
Male 25(76) 69(80)  
Female 8(24) 17(20)  
Age, mean (sd) 53(14) 56(13) 0.456*** 
Witnessed apneas, n (%) 21(64) 56(65) 0.469* 
Alcohol before sleep, n (%) 17(52) 38(44) 0.466* 
BMI, mean (sd) 29(5) 29(4) 0.839*** 
NC, mean (sd) 41(3) 41(4) 0.879*** 
AC, mean (sd) 105(12) 105(12) 0.744*** 
ACr increased, n (%) 31(94) 75(90) 0.723** 
NCr increased, n (%) 16(49) 36(43) 0.664* 
BMIr Obese, n (%) 12(37) 31(36) 0.956* 
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5.4.1. Logistic regression model 
 
We applied, using the same cutoffs of the LR model, the same regression equation to the data collected on 
the second cohort. Using the 10% cutoff, defined for a 100% of sensitivity, the model obtained 100% for 
sensitivity and 0% for specificity, while using the 25% cutoff, to a 95% of sensitivity, the sensitivity value 
decreased to 88% but we obtained better specificity (15%). In this last scenario, the model missed two 
OSA cases: one mild (female, not obese, with PC and NC increased but with no witnessed apneas, with 
border line result of 5.8 apneas/hour) and one severe (male, not obese, with NC normal, NA increased 
and a border line result of 33 apneas/hour). 
 
5.4.2. Tree Augmented Bayesian Network and Naïve Bayes 
 
Comparing the results of the two BN models (table 8) aiming 100% for sensitivity, TAN and NB had the 
same result for sensitivity (94%) on the test sample, but TAN achieved better results on specificity (7%) 
than NB (0%). The same sensitivity (89%) occurs aiming 95% but TAN (13%) achieved better results for 
specificity than NB (7%). 
 
Table 8 summarizes the results of the three models results on train and test sample.  
 
Table 8: Results of LR and BN on the train and test sample 
 LR  TAN  NB 
 Cutoff Sens Spec  Cutoff Sens Spec  Cutoff Sens Spec 
Train            
Baseline, (%) 50 71 73  50 70 73  50 70 73 
Aiming 95%, (%) 25 95 35  22 95 38  10 98 33 
Aiming 100%, (%) 10 100 5  2 100 28  7 100 25 
CV            
Baseline, (%) 50 73 62  50 65 73  50 67 73 
Aiming 95%, (%) 25 89 34  22 84 25  10 93 30 
Aiming 100%, (%) 10 98 11  2 88 23  7 98 18 
Test            
Baseline, (%) 50 56 39  50 72 53  50 56 47 
Aiming 95%, (%) 25 88 15  22 89 13  10 89 7 
Aiming 100%, (%) 10 100 0  2 94 7  7 94 0 
LR: logistic regression; NB: Naive Bayes; BN: Bayesian networks; TAN: tree augmented Bayesian network, Sens: sensitivity, Spec: 
specificity; CV: cross-validation. 
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6. Discussion 
The initial step towards defining a decision support system is to assess the need for it. In the two samples, 
the proportion of normal results was 48% and 45% on train and test sample, respectively, which reveals a 
large number of normal exams, as we expected, hence supporting the need for a good clinical decision 
support system to prioritize the waiting list. 
 
Although the large number of clinical variables used (33), only six had significant results in the univariate 
analysis: body mass index, neck circumference (NC), abdominal circumference, gender, witnessed apneas 
(WA) and consume of alcohol before sleep. In our study, WA was more frequent in male gender, what is 
according with the literature. One possible explanation of some authors, referred on background, for the 
detection of WA, is that it appears more frequent in males, because female bed partners of male patients 
appear to have a lower threshold for symptom perception and reporting than male bed partners of female 
patients. Even though in some studies, age appears as a risk factor, in our study it did not end up having 
significant odd ration (OR) on the univariate analysis. In other hand, these results confirm the inability of 
some models founded in literature that not considered NC as a risk factor. Because this factor is not 
described in some articles as important to the development of obstructive sleep apnea (OSA), some 
physician’s don´t collect this information on the consultation and our study, one more time, supports the 
importance of this measure. Even the multivariate logistic regression (LR) model showed that the most 
discriminative predictive factors for the presence of OSA were the neck circumference and witnessed 
apneas, which is in accordance with other studies, and supports the inability of some other models that 
were not build using these factors, in proper prediction of OSA . 
 
The developed models, logistic regression (LR) and Bayesian networks (BN) based, were analyzed 
considering two different levels for sensitivity. First, models were fitted for 100% sensitivity to avoid false 
negatives. It was our goal prioritize patients on the waiting list, eventually reduce the number of normal 
exams performed, but we can´t leave patients with moderate or severe OSA without performing 
polysomnography (PSG). To allow a not so strict level of sensitivity, we experimented also 95%, useful for 
hospitals with sleep consultation but without sleep laboratory (which have to choose very well patients to 
refer to other laboratories), which achieved much better results for specificity. 
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6.1. Overall evaluation 
 
On LR, for 100% sensitivity, we used a cutoff of 10% over the multivariate model's output probability, 
achieving a sensitivity of 100% and a specificity of 5% in our sample, and 98% and 11% using cross-
validation. The values obtained for sensitivity suggests that this approach should evolve towards a clinical 
decision support system: 100% sensitivity, with high negative predictive value and enough specificity. We 
achieved a specificity of 35% for a sensitivity of 95% (34% and 89%, respectively, in cross-validation), by 
choosing a cutoff value of 25%.  
 
When we tested our model in a second comparable cohort, the LR model using the 10% cutoff avoids 
false negatives but does not reduce the number of normal patients requested to perform PSG. However, 
this was an expected result given the reduced size of the sample (5% specificity over 15 normal patients 
represents less than one patient). Using a higher cutoff (25%), the result was good for specificity (15%) 
but with loss of sensitivity, 88%. Nevertheless, as further explained, we believe that the two OSA patients 
missed by the model do not hinder the validity of the proposal. First, since the cutoff was optimized for 
95% sensitivity, we would expect one OSA patient to be missed (in this case, the mild OSA patient). 
Then, the severe OSA patient missed by the model actually presented negative values for the two included 
variables (WA and NC), and could thus be considered an outlier for our modeling.  
 
Considering these results, if we based our clinical decision support system on LR model results, we could 
foreseen a clinical practice decision support tool with three levels: 
1. classify in non-priority group, or avoid requesting PSG, the patients with a probability under 10%; 
2. classify in a intermediate level of priority patients in the waiting list for PSG with a probability 
between 10 and 25%; 
3. classify in a priority group patients in the waiting list for PSG with a probability above 25%. 
 
Although a model with only two parameters can be simple to apply in clinical practice, the fact that one of 
them (witnessed apneas), is not possible to be measured directly (is in fact dependent of partner 
recognition) or, in some cases, even impossible to determine (if the patient lived alone), might prevent 
better results of this model's application. 
 
Overall, neck circumference and witnessed apneas information suffices to a logistic regression-based 
clinical model that can be used to attribute priorities to patients in the waiting lists for PSG, classifying in 
non-priority group patients in the waiting list with a probability under 25%. At least this model can 
decrease the number PSG requests, avoiding this exam in the patients with a lower probability.  
 
 The significant variables achieved in univariate analysis were used to create the BN using naïve Bayes (NB) 
and tree augmented Bayesian network (TAN) classifiers. Aiming 100% of sensitivity, we used a cutoff of 
7% and 2% for NB and TAN respectively. On internal validation either reveals the same sensitivity, 
100%, but TAN had better sensitivity (28%) than NB (25%). The results of sensitivity on leave-one-out 
CV were better in NB (98%) than in TAN (88%), but TAN had superior specificity results (23%) than NB 
(18%). If we aim at 95% of sensitivity the cutoff used on NB was 10% and for TAN was 22%. On 
internal validation, NB had better sensitivity (98%) and worse specificity than TAN (95% and 38%). On 
CV, NB had better results (93% and 30%) than TAN (84% and 25%). 
 
Based on the results of CV, we expected better results of NB for sensitivity, using both cutoffs and also 
better specificity aiming 95%, but worse results of specificity than TAN aiming 100%. In fact, when we 
applied the test sample to our BN models, the results for sensitivity were the same on NB and TAN (94% 
and 89%) using the two types of cutoff, but the results of specificity were better on TAN (7% and 13%) 
in the two alternatives when compared with NB (0% and 7%). 
 
As we suggested to the LR model based, we can use these cutoffs results to check priorities to patients 
recommended to perform PSG using the NB and TAN classifiers: 
 
1. classify in non-priority group, or avoid requesting PSG, patients with a probability under 2% 
using TAN and 7% using NB; 
2. classify in an intermediate level of priority patients in the waiting list for PSG with a probability 
between 2% and 22% using TAN and between 7% and 10% using NB; 
3. classify in a priority group patients in the waiting list for PSG with a probability above 22% using 
TAN and 10% using NB. 
 
To apply these models on clinical practice we can create a model that uses the two classifiers, NB and 
TAN. This way, we can create multiple models, based on consensus or not, that compensate the TAN 
variability with the bias of NB. 
 
6.2. Inference 
 
To explain how the BN can be implemented in a clinical decision support system, we apply the 
information of one patient tested in various hypothesis of inference. Observed variables are marked red 
(100%). 
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Entered a new patient, female, without witnessed apneas nor alcohol consumption before sleep with AC, 
NC and normal BMI, the probability of OSA result is 1.27% using NB (fig. 11) and higher (21.51%) using 
TAN (fig.12): 
 
 
Figure 11: Inference using NB with new evidence: female, without WA nor alcohol consumption before sleep with AC, NC and 
BMI normal 
(WA: Witnessed Apneas, BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference). 
 
 
 
Figure 12: Inference using TAN with new evidence: with new evidence: female, without WA nor alcohol consumption before 
sleep with AC, NC and BMI normal 
(WA: Witnessed Apneas, BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference). 
 
 This patient, according to the NB results, had a lower probability of OSA and so, we could consider a 
non-priority PSG request. The results of PSG confirm this approach, as the result was normal (AHI was 
0/h ). However, TAN would recommend intermediate level of priority. 
 
Another advantage of BN is the fact that they can deal with missing information. To use the LR model, 
we need to have access to the two variables present on the regression equation: NC, easy to determine and 
WA, not so easy, subjective and, in some cases, impossible to achieve. 
 
Imagine that, in the case that we presented above, we don´t have access to WA. We can use BN without 
this information as the probabilities values obtained are based on the learning process that the network 
made with the information of other patients. The results of NB (fig. 13) showed a probability of 3.26% 
and 35.92% on TAN. 
 
Figure 13: Inference using NB with missing information of WA 
 (WA: Witnessed Apneas, BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference). 
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Figure 14: Inference using TAN with missing information of WA 
(WA: Witnessed Apneas, BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference). 
One more time, NB results were closer to the real result and even without information of WA, the 
probability of OSA was low. 
 
Suppose that the same patient is recommended to the sleep laboratory to perform PSG by telemedicine or 
we have access to her electronic registers, but not to the patient, and we want to prioritize based on the 
information given: only that is a female, with normal BMI and alcohol consumption before sleep. This 
situation shows the importance of these models, dealing without information of more than one variable, 
when we have the impossibility of measuring some missing variables (fig. 15 and 16). 
 
 
Figure 15: Inference using NB with missing information of WA, AC and NC 
(WA: Witnessed Apneas, BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference). 
  
Figure 16: Inference using TAN with missing information of WA, AC and NC  
(WA: Witnessed Apneas, BMI: Body Mass Index; NC: Neck circumference; AC: Abdominal circumference). 
Comparing these probabilities to the results of figure 13 and 14, we verify that probability for OSA 
diagnosis decrease using TAN (17.41%) and increase using NB (27.22%) with the lack of information of 
three variables. If we used the prioritization suggested above using TAN, this patient would be classified 
as a non-priority group even with only three parameters (gender, alcohol and BMI). These examples 
shows the bias of NB to classify new cases with missing information and the capability of TAN to deal 
with these situations as it uses one more variable dependence to classify.  
 
Besides the advantages described above on dealing with missing information, the graphical representation 
must be seen as another capital gain, mainly the TAN model, that shows more than one dependence 
between the variables. This is an advantage comparatively to LR based models that don´t have this 
capability. 
 
6.3. Limitations 
 
Some factors were not possible to assess due to the lack of representativeness in the sample (ethnicity, 
snore, decreased libido, pulmonary hypertension, congestive heart failure, metabolic syndrome, renal 
failure and hypothyroidism) which may have led to a somewhat biased model. Also, because our study was 
conducted on patients referred by primary care physicians to the sleep consult, the prevalence of OSA in 
our sample (52%) was higher than of general populations. Hence, no OSA prevalence estimate can be 
inferred. 
 
To recode the continuous variables, NC, AC and BMI, we used measures that we found on literature, but 
there are no standard values to categorized values into normal or altered, so these may lead to some errors 
in border line characteristics. Here we used value higher than 30 to recode into obese, some authors can 
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considered 25 (pre-obese). To recode NC and AC we chose the most referred and consensual values 
criteria on literature but other could exist. 
 
Other question is the metric used to classify OSA. As we explained on background some authors 
questioned if AHI is the more accurate measure to classify OSA severity. Some suggest the use of RDI in 
alternative to AHI.  
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7. Conclusions and recommendations 
In this study the main characteristics for obstructive sleep apnea (OSA) were body mass index, neck 
circumference, abdominal circumference, gender, witnessed apneas and consume of alcohol before sleep. 
 
We used two different techniques to construct the models, one based on logistic regression (LR) and other 
on Bayesian networks (BN). Using these two techniques, LR and BN, we did not aim to compare the two 
models directly, but rather show their results to facilitate choices and possibly, complement the two 
methods. They must be seen has methods that support decisions but do not substitute the physician that 
has always, according to the clinical history of the patient, the last decision. 
 
With LR, the final model used only two variables on the regression equation: neck circumference and 
witnessed apneas. The great limitation on the application of this approach is the use of WA, since it is 
subjective and in some cases impossible to measure. 
 
The great advantages of BN are the fact that they can deal with missing information and the graphical 
representation that shows not only the values of probabilities given the patient characteristics, but also 
represents the relationship between variables. This can be an alternative to the traditional statistical 
measure, odds ratio (OR), that can be interpreted as a relative risk of disease in exposed or not exposed 
patients. 
 
As we did not find a validated model, tested in Portuguese sleep laboratories, we think that our models 
consist in a valid method to screen patients with suspicion of OSA, before performing PSG.  
 
The great advantage of our solutions is prioritizing OSA suspicion patients into different levels of priority 
according to their characteristics, and consequently, their probability of confirming the OSA diagnosis. 
Other advantage is that the system could manage waiting lists automatically in consultation when the 
physician inserts patient data. 
 
Eventually, we can reduce the number of normal result exams, optimizing the available resources and 
making sure that no severe case waits much to time and, consequently, treatment.  
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8. Future work 
Would be interesting to test these models in a multi-center sleep laboratories study to compare our results 
to others before implementing a decision support system that can be used during pre-polysomnography 
consultation. This clinical decision support system could be based on multiple models, tested in this work, 
like logistic regression and Bayesian networks using naïve Bayes and tree augmented Bayesian network. 
 
As the sleep laboratories have also a high number of patients referred by the primary care, we could 
perform another study to implement a decision support system to help primary care physicians with the 
decision to send patients to sleep consultation and in this way, prioritize waiting lists for consultation. 
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International Classification of Sleep Disorders 
 
 
I Dyssomnias 
 
A. Intrinsic Sleep Disorders 
 
1. Psychophysical Insomnia 
2. sleep State Misperception 
3. Idiopathic Insomnia 
4. Narcolepsy 
5. Recurrent Hypersomnia 
6. Idiopathic Hypersomnia 
7. posttraumatic hypersomnia 
8. Obstructive Sleep Apnea Syndrome  
9. Central Sleep Apnea Syndrome 
10. Central Alveolar Hypoventilation Syndrome 
11. Periodic Limb Movements Syndrome 
12. Resteless Legs Syndrome 
13. Intrinsic Sleep Disorders NOS 
 
B. Extrinsic sleep disorders 
 
1. Inadequate Sleep Hygiene 
2. Environmental Sleep Disorder 
3. Altitude Insomnia 
4. Adjustment Sleep Disorder 
5. Insufficient Sleep Syndrome 
6. Limit-Setting Sleep Disorder 
7. Sleep-Onset Association Disorder 
8. Food Allergy Insomnia 
9. Nocturnal Eating (drinking) Syndrome 
10. Hypnotic-Dependant Sleep Disorder 
11. Stimulant-Dependant Sleep Disorder 
12. Alcohol-Dependant Sleep Disorder 
 13. Toxin-Induced Sleep Disorder 
14. Extrinsic Sleep Disorder NOS 
 
C. Circadian Rhythm Sleep Disorder 
 
1. Time Zone Change (jet lag) Syndrome 
2. Shift Work Sleep Disorder 
3. Irregular Sleep-Wake Pattern 
4. Delayed Sleep Phase Syndrome 
5. Advanced Sleep Phase Syndorme 
6. Non-24-hour Sleep-Wake Disorder 
7. Circadian Rhythm Sleep Disorder NOS 
 
 
II Parasomnias 
 
A. Arousal disorder 
 
1. Confusional Arousal 
2. Sleepwalking 
3. Sleep Terrors 
 
B. Sleep-Wake Transition Disorders 
 
1. Rhythmic Movement Disorder 
2. Sleep Starts 
3. Sleep Talking 
4. Nocturnal Leg Cramps 
 
C. Parasomnias Usually Associated With REM Sleep 
 
1. Nightmares 
2. Sleep Paralysis 
3. Impaired Sleep-Related Penile Erections 
4. Sleep-Related Painful Erections 
5. REM Sleep-Related Sinus Arrest 
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6. REM Sleep-Behaviour Disorder 
 
D. Other Parasomnias 
 
1. Sleep Bruxism 
2. Sleep Enuresis 
3. Sleep-Related Abnormal Swallowing Syndrome 
4. Nocturnal Paroxysmal Dystonia 
5. Sudden Unexplained Nocturnal Death Syndrome 
6. Primary Snoring 
7. Infant Sleep Apnea 
8. Congenital Central Hypoventilation Syndrome 
9. Sudden Infant Death Syndrome 
10. Benign Neonatal Sleep Myoclonus 
11. Other Parasomnia NOS 
 
 
III Sleep Disorders Associated With Medical / Psychiatric Disorders 
 
A. Associated With Mental Disorders 
1. Psychoses 
2. Mood Disorders 
3. Anxiety Disorders 
4. Alcoholism 
 
B. Associated With Neurological Disorders 
 
1. Cerebral Degenerative Disorders 
2. Dementia 
3. Parkinsonism 
4. Fatal Familial Insomnia 
5. Sleep-Related Epilepsy 
6. Electrical Status Epilepticus of Sleep  
7. Sleep-Related Headaches 
 
C. Associated With Other Medical Disorders 
  
 
1. Sleeping Sickness 
2. Nocturnal Cardiac Ischemia 
3. Chronic Obstructive Pulmonary Disease 
4. Sleep-Related Asthma 
5. Sleep-Related Gastroesophageal Reflux 
6.  Peptic Ulcer Didease 
7. Fibrositis Syndorme 
 
 
IV. Proposed Sleep Disorders 
 
1. Short Sleeper 
2. Long Sleeper 
3. Subwakefulness Syndorme 
4. Fragmentary Myoclonus 
5. Sleep Hyperthidrosis 
6. Menstrual-Associated Sleep Disorder 
7. Pregnancy-Associated Sleep Disorder 
8. Terrifying Hypnagogic Hallucinations 
9. Sleep-Related Neurogenic Tachypnea 
10. Sleep-Related Laryngospasm 
11. Sleep Chocking Syndrome 
12. Classification of sleep disorders 
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SPECIFICATIONS 
Digital Specifications for Routine PSG Recordings 
 
 
Sampling rates Frequency 
EEG 500Hz 
EOG 500Hz 
EMG 500Hz 
ECG 500Hz 
Airflow 100Hz 
Oximetry 25Hz 
Nasal pressure 100Hz 
Body position 1Hz 
Snoring 500Hz 
Rib Cage and Abdominal Movements 100Hz 
 
 
 
Filter settings Low frequency filter High frequency filter 
EEG 0.3Hz 35Hz 
EOG 0.3Hz 35Hz 
EMG 10Hz 100Hz 
ECG 0.3Hz 70Hz 
Respiration 0.1Hz 15Hz 
Snoring 10Hz 100Hz 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Epworth Somnolence Scale (ESS) 
 
How likely are you to doze off or fall asleep in the following situations, in contrast to feeling just tired? 
This refers to your usual way of life in recent times. 
Even if you have not done some of these things recently, try to work out how they would have affected 
you. Use the following scale to choose the most appropriate number for each situation: 
0 = Would NEVER doze 
1 = SLIGHT chance of dozing 
2 = MODERATE chance of dozing 
3 = HIGH chance of dozing 
Situation Change of dozing 
Sitting and reading 
 
 
Watching television 
 
 
Sitting, inactive in a public place 
(for example, a theater or a meeting) 
 
 
As a passenger in a car 
 
for an hour without a break 
 
 
Lying down to rest in the afternoon 
when circumstances permit 
 
 
Sitting and talking to someone 
 
 
Sitting quietly after a lunch 
without alcohol 
 
 
In a car, while stopped for a few 
minutes in traffic 
 
Each question is scored from 0 to 3, giving a maximum score of 24. 
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CONSENTIMENTO INFORMADO 
 
Liliana Patrícia Pinto Leite, aluna de mestrado em Informática Médica da Faculdade de Medicina da 
Universidade do Porto pretende realizar investigação, no âmbito da sua dissertação, recolhendo dados de 
indivíduos sugeridos para realizarem polissonografia no laboratório de estudos do sono do Centro 
Hospitalar de Vila Nova de Gaia/Espinho, EPE. 
 O presente estudo tem como objectivo a construção de vários modelos, construídos quer com 
base em características dos doentes quer através de ferramentas de data mining e a comparação 
dos seus resultados de forma a avaliar qual o modelo que obtém maior validade, optimizando a 
sensibilidade para a predição dos casos mais prováveis de doença. 
 A recolha de dados é efectuada uma vez aquando a realização da polissonografia; 
 Não estão presentes benefícios ou riscos para o sujeito; 
 Será mantida a confidencialidade de todos os dados relativos ao sujeito; 
 O sujeito poderá desistir da participação na investigação em qualquer altura, sem ter de dar 
explicações, apresentar desculpas ou reembolsar despesas; 
 O investigador usará de franqueza durante todo o processo, limitando o conhecimento do sujeito 
aos dados por ele designados como fundamentais face ao objectivo da experiência. 
 
Eu, abaixo assinado_______________________________________________________ 
declaro que entendo os objectivos, características e duração do estudo e que é de minha livre vontade que 
participo no mesmo. 
_________________________________ 
____/____/_______ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Authorization for study realization  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
